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Executive Summary 
 
Background 
 
In 2003, the General Register Office for Scotland (GROS) reported the highest 
ever annual number of drug related deaths - 382 deaths during 20021.  The 
Scottish Deputy Justice Minister subsequently called for a national investigation 
into all drug-related deaths in Scotland for the year 2003.  This paper 
summarizes the outcomes of that investigation. 
 
Aims and Objectives 
 
The main aims of the study were to collect and analyse information relating to the 
clinical and social circumstances surrounding all drug-related deaths in Scotland 
from January – December 2003, to identify patterns in these circumstances and 
the associations between them, and to make recommendations for policy and 
practice which may lead to a future reduction in drug-related deaths. 
The main objectives of the investigation were to: 
 
• Establish and explore the nature of the individual’s social circumstances prior 
to death 
• Determine the specific combinations of drugs associated with each death 
• Establish the nature and extent of contact with “services” prior to their death  
• Investigate patterns in broad demographic variables of drug related deaths for 
the period 1996 – 2003. 
 
In addition, injectors who had survived an overdose in the previous 6 months 
were interviewed to obtain more information about their beliefs, experiences and 
knowledge of overdose, and characteristics of Scottish drug-related deaths were 
compared with a sample of London drug deaths for the same year (2003). 
 
Methods 
  
(1) Drug related deaths in Scotland, 2003 
 
The study population comprised 317 cases of drug-related death in 2003 
identified by GROS2. Information on each person’s clinical and social 
circumstances was obtained from case records held by social care services, 
specialist drug treatment services, mental health services, and non-statutory 
agencies across all health board areas in Scotland. Information was also collected 
from the Scottish Prisons Service (SPS), Scottish Criminal Records Office (SCRO), 
Practitioner Services Division (PSD) and Information and Statistics Division (ISD) 
of the Common Services Agency. Data on the circumstances of death, post-
mortem toxicological findings and cause of death were sourced from fiscal files. 
  
The following variables were collected: sociodemographic characteristics including 
accommodation and employment status, circumstances of death and post-
mortem toxicology findings, cause of death, pattern of contact with health, social 
and criminal justice agencies in the 6 months prior to death. In total, 175 
agencies were contacted, with 173 (99%) giving permission for access to their 
records.  
 
                                          
1 General Register Office for Scotland (2003) Drug related deaths in Scotland, 2002. http://www.gro-
scotland.gov.uk/statistics/library/drug-related-deaths/ 
2 Definitions of drug related deaths were based on ICD-10 codes for drug related death categories.   
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(2) Trends in drug related deaths in Scotland, 1996-2003 
 
Data collected by GROS on drug-related deaths in Scotland from 1996-2003 were 
examined for trends in all deaths and those involving heroin/morphine or 
methadone.  Analysis focused on changes in drug-related deaths during this 
period, and specifically on cause of death, day of death, gender, age, health-
board area and drugs specified on the death certificate. 
 
(3) Experiences of overdose survivors 
 
A sample of 40 injecting drug users (IDUs) were interviewed3. A multiple site 
recruitment strategy generated a representative sample of Glasgow IDUs.  
 
(4) Comparison of Scottish and London drug related deaths 
 
The Scottish data were extracted from Procurator Fiscal files.  London coronial 
data were extracted from seven coronial courts, accounting for approximately 
75% of drug related deaths in London.  Analyses assessed differences between 
London (n=148) and Scotland (n=273) in terms of age, gender, toxicology, 
homelessness, history of imprisonment, drug treatment, place of death, number 
of witnesses and ambulance attendance. 
 
Results 
 
The study population and trends over time 
 
Most (81%) Scottish drug related deaths in 2003 were male. The mean age was 
32.7 years (ranging between ages 16 to 82 years). Thirty-nine per cent were 
aged between 25 and 34 years.  Most (68%) cases were accidental drug 
overdoses. Thirteen per cent were classified as suicides. 
During the period 1996-2003 in Scotland, drug-related deaths involving 
heroin/morphine had increased (+13.8% yearly), while those involving 
methadone had decreased (–0.4% yearly). A higher proportion of methadone 
compared to heroin/morphine–related deaths in Scotland occurred at the 
weekend (Friday to Sunday). Drug-related deaths had increased at a significantly 
higher rate among those aged 35-54 compared to 15-24 years. 
Circumstances of death and toxicological findings 
 
At the time of death, nearly half (48%) of overdoses occurred in the vicinity of 
other persons. Most (68%) deaths occurred in a home environment, either in 
their own home or in a friend’s place. Few deaths (8%) occurred 
‘instantaneously’. Where others were present, CPR was attempted in 44% of 
cases, however no intervention occurred (prior to the arrival of the ambulance) in 
38%. Although an ambulance was called to the scene in 82% of cases, for most 
victims (81%), it was too late. 
 
The predominant drugs found at the time of death were benzodiazepines (69%), 
heroin/morphine (60%), and alcohol (57%). Just over a quarter (28%) of the 
sample was positive for methadone. Few cases were positive for stimulants; 9% 
were positive for cocaine. More than one drug was detected in the vast majority 
(95%) of cases. Nearly half of methadone positive deaths, and two-thirds of 
diazepam and dihydrocodeine positive deaths, involved illicit sources of 
                                          
3 As part of an ongoing evaluation of the Lord Advocate's guidance on the distribution of sterile 
needles and syringes to injecting drug users (see SMRT website for further details). 
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medications. Injection was the route of administration in 46% of cases.  However 
a relatively high proportion (44%) of individuals did not inject any drugs prior to 
overdose and death4, and a high proportion (36%) were positive for only orally 
consumed drugs.   
 
‘Opiate intoxication’ was the most frequently recorded cause of death (44% of 
cases). In the majority (91%) of these cases, however, toxicology identified other 
drugs in addition to opiates - mainly benzodiazepines and alcohol. 
 
In Scotland there was a higher proportion of deaths positive for dihydrocodeine 
(19% vs. 11%) and benzodiazepines (69% vs. 41%), a higher proportion of 
cases in receipt of dihydrocodeine prescriptions (8.4% vs. 2.7%), lower average  
blood concentrations (mg/L) of methadone (0.52 vs. 0.87) and morphine (0.27 
vs. 0.36) and a higher proportion of deaths (17% vs. 10%) associated with 
recent prison release5 compared with London. A higher proportion of deaths in 
London was positive for cocaine (42% vs. 10%).  
 
Social circumstances prior to death 
 
Most (237, or 75%) of the 317 people had been in contact with services in the six 
months prior to their death. Of this 237, 117 (49%) were living in their own 
house or flat. Thirty one (31%) were in unstable or temporary accommodation. 
Eight were recorded as having been roofless during the six months prior to death. 
Of the 138 for whom information on living arrangements was available, 74 (54%) 
lived alone and 64 (46%) lived with others. Twenty-nine of those were recorded 
as living with a partner, 32 with parents and 3 with dependent children. 
 
Casefiles show that 119 (50%) had children while 55 (23%) did not6. The 119 
who were identified as parents, had 185 children. Seventeen of these children 
(9%) were recorded as living with a parent who died of drug-related causes. 
Seventy-eight (42%) were living elsewhere and 2 were in care. No information on 
where these children were living was available in 88 (48%) casefiles.  Of 59 
females who died, casefiles record that 16 (27%) had children in their care at the 
time of their death. 
 
Contact with services 
 
The frequency of service contacts remained constant across each of the six 
months prior to death. Forty-five percent of those accessing services were in 
contact with 2 or more services at any one time. A significant proportion of 
contact was with General Practitioners (GPs) - 183 (77%) of all those in contact 
with services accessed GPs during this period. In most areas, the majority of 
contact was with generic providers rather than specialist drug services. Overall 
only 40 (17%) were known to specialist services, while in most areas there were 
significant contacts with psychiatric services (41 people, 17%), acute services – 
including Accident & Emergency (59 people, 22%) and NHS outpatients of various 
types (37 people, 15%). In total, 71 (30%) were known to Social Work. 
Half (138) of the 237 people in contact with services had details of previous 
overdoses recorded in their notes. During the 6 months prior to death, 31 had 
experienced at least one overdose. Nine of those were recorded as accidental, 13 
deliberate and 9 not known. 
Sixty-six people were prescribed methadone during the six months prior to death, 
and 40 were being prescribed methadone at their time of death. Doses ranged 
                                          
4 Route of administration was unknown in 11% of cases. 
5 Within 3 months of release. 
6 No information was available in 63 casefiles (27%). 
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between 4 and 100 mg (mean 53.9 mg). Sixteen of these people (34%) were 
prescribed 60 mg or more. At time of death, twenty-one people (54%) were 
having their methadone dose increased and 8 (20%) were being reduced7. Only 7 
(11%) were also receiving regular counselling during that time; there was no 
evidence of counselling taking place for the remainder of this group. 
 
Of the total 317 cases, 149 (47%) had previously had a prison sentence. 70 
(47%) died within 6 months of release. Thirty-six of these deaths (24%) occurred 
within one month, and 10 (28%) occurred within three days of release. While 
Transitional Care or other throughcare support was available to prisoners during 
this period, prisons show varying success regarding take-up rates. 
 
Experiences of overdose survivors 
 
Overdose survivors were interviewed about their experience of overdose in the 
previous 6 months. Most had taken more than one substance that day.  Heroin 
had been taken by all but one, and heroin and diazepam taken together or on the 
same day was the most common combination.  
 
Interviewees had some awareness of overdose risk. However, this knowledge was 
not extensive and there were misconceptions.  Less than half mentioned 
tolerance as a factor or considered that a mixture of drugs could be risky. Some 
believed that overdose would not occur if heroin was smoked or injected by itself.  
Injecting in company was the most frequently cited prevention strategy. 
 
Inflicting physical pain was the most common intervention used by injecting drug 
users to revive an overdose survivor, and was regarded as the most effective 
strategy.  Putting the overdose victim into the recovery position was cited by half 
the sample. Half were worried about having another overdose.  Among those who 
were not worried, some claimed not to care whether they lived or died. 
 
Implications and conclusions 
 
This investigation has identified implications for services in preventing drug-
related deaths, and has highlighted limitations of the available data: 
 
• There is a need to further develop and deliver training and education on risks 
of overdose and how to respond effectively, to drug users and their families. 
• Overdose prevention initiatives should continue to emphasise that most fatal 
drug overdoses are polydrug deaths.  
• Primary care and other ‘generic’ services need training to increase awareness 
of persons at high risk of drug related death.  
• Delivery of medical treatment to drug misusers, including substitute 
prescribing, needs to be improved in line with best practice guidelines. 
• Care pathways across the prison/community interface should be reviewed to 
ensure adequate accessibility to services for all newly released prisoners. 
• Developing a standardised nomenclature for recording drug related deaths 
would improve surveillance of trends in drug related deaths. 
• There is a need to improve the quality of record keeping in services.  
 
Finally, the report provides some baseline indicators by which the effectiveness of 
interventions to prevent or reduce drug-related death might be measured.   
                                          
7 In 11 cases, there was inadequate information in casefiles to determine prescribing plans or trends. 
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What is in this chapter? This chapter summarises the information that is 
already known about drug related deaths.  It describes the background to the 
commissioning of this study, sets out the aims and objectives and describes 
the methods employed to meet these. 
 
Where did the information come from? The background section is drawn 
from published international research. 
 
Chapter 1:  Introduction  
 
Purpose of this report 
 
In 2003, the General Register Office for Scotland (GROS) reported the country’s 
highest ever annual number of drug related deaths, 382 deaths during 2002 
(GROS 2003).  The Scottish Deputy Justice Minister subsequently called for a 
national investigation into all drug related deaths in Scotland for the year 2003.  
This report is the outcome of that investigation. 
 
A great deal is already known about the circumstances and toxicological findings 
of drug related deaths (DRDs), especially those involving heroin and methadone.  
There is now a strong research evidence base indicating that many of these 
deaths are preventable.  However, less is known about the social and clinical 
circumstances of these individuals prior to their deaths, in particular the nature of 
contact made with treatment agencies, prison service and other services.  This 
study explores the patterns of contact with service providers in the 6 months 
prior to death, and examines implications of these findings for services.  It 
provides the most recent information to date on the toxicology and circumstances 
of death of drug-related deaths in Scotland, and compares these findings with 
data emerging from a concurrent study into drug-related deaths in London for the 
same year.  The opinions, beliefs and knowledge of a group of living injectors who 
have survived a recent overdose are also reported here. 
 
Background 
 
Known characteristics of drug related deaths 
 
Remarkably, the characteristics, correlates and contexts of opioid drug related 
deaths examined in different countries and at different times are consistent (Best 
et al 2000).  Consistent findings include: 
 
• High prevalence of poly-drug use, especially benzodiazepines and alcohol 
(Darke and Zador 1996, Risser et al 2000, Oliver and Keen 2003) 
• Loss of tolerance due to recent abstinence from heroin e.g. persons recently 
released from prison or abstinence based inpatient programmes (Seaman et 
al 1998, Bird and Hutchinson 2003, Strang et al 2003) 
• Deaths occurring in the presence of others and/or in a home environment. 
(Zador et al 1996, Darke et al 2000, np-SAD 2002) 
  
All of these circumstantial factors strongly imply the opportunity for intervention 
prior to death.  
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White and Irvine (1999) have speculated that resistance to respiratory depression 
may be less complete and fall more rapidly than resistance to the ‘euphoric’ 
effects of heroin.  Thus, as injectors consume more drugs the gap between 
euphoria and overdose narrows, and any ‘dip’ in tolerance due to interruptions in 
drug use precipitated by imprisonment, treatment or unfamiliar environment may 
prove fatal (White and Irvine 1999, Siegel 1984). 
 
Route of administration is also predictive of increased mortality.  Most heroin 
related deaths have occurred following an intravenous injection (Darke et al 
2000).  Overdose events were rare among smokers of heroin (Gossop et al 
1996).  Oliver and Keen (2003) recently confirmed these findings when they 
reported that the intravenous route of administration was used in 84% of DRDs in 
Sheffield, England. 
 
Methadone related deaths, as for heroin deaths have been found to be primarily 
poly-drug deaths, few are positive only for methadone (Perret et al 2000, Sunjic 
and Zador 1999).  An international review of methadone related deaths indicated 
that the majority were diversion related i.e. occurring in persons not prescribed 
methadone at time of death (Zador 1999), a finding replicated by the most recent 
published Scottish investigation of methadone related deaths (Seymour et al 
2003). 
 
Further examination of the death certificates and coronial records in the NTORS 
cohort (Gossop et al 2002) were consistent with previous findings: the majority of 
deaths were found to be accidental, with more than one drug being detected at 
autopsy in most cases, occurring in a home environment, and with half of cases 
dying in the vicinity of another person.  Non-prescribed benzodiazepine use, 
harmful alcohol consumption, anxiety and homelessness were found to be 
predictive of increased mortality. 
 
Scottish data on all drug related deaths (GROS 2003) in 2002 indicated that the 
sociodemographic profile, toxicological findings and circumstances of death had 
remained largely unchanged.  Most cases of DRD continued to occur in males 
under the age of 45 years, predominantly involved heroin/morphine with a high 
proportion positive for benzodiazepines and alcohol, and primarily occurred in 
known or suspected drug abusers. 
 
Long term trends of drug-related mortality and fatal overdose suggest that they 
may have fallen from over 2% per annum among opiate users recruited from 
1968-1976 to 1% in 1986-1992 (Ghodse et al 1998).  Two recent record linkage 
studies in the UK reported that among the NTORS cohort the annual mortality 
rate was 1.2% after four years follow-up (Gossop et al 2002), and in a pilot 
cohort recruited in London the annual mortality was 1.6% after an average of two 
years follow-up, 17 times higher than the mortality rate of the London population 
(Hickman et al 2003a).  
 
Among Glasgow injectors followed up after entry to methadone treatment in 
1996, 1.5% died in the first year (Hutchinson et al 2000), and this annual rate 
was sustained in the subsequent 4-5 years.  
 
Risser et al (1996) established a profile of the family background of Austrian 
cases of drug related death based on interviews with family members of the 
deceased.  This study found that cases experienced high rates of traumatic 
events during childhood, predominantly parental divorce or death, initiated 
alcohol and tobacco smoking by age 15, and that a high proportion of cases had a 
family member with a drinking problem, among other findings.  This highlights 
the importance of the social and family contexts of DRDs. 
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Research into DRDs is now building on the above findings to examine the 
implications for prevention i.e. interventions to reduce DRDs. 
 
Survivors of drug overdose 
 
It is instructive to note the findings from research to date into survivors of drug 
overdose.  Neale (2000) interviewed 77 resuscitated heroin users in two Scottish 
accident and emergency departments, and found that attempted suicide was the 
reason underlying the overdose in 49%.  However, interviews with a sample of 
Australian drug users found that deliberate heroin overdose as a method for 
attempting suicide was reported by only 10% (Darke and Ross 2001).  These 
authors followed up with an international literature review of rates, risk factors 
and methods of suicide among heroin users and found that while this group was 
14 times more likely than peers to die from suicide, deliberate overdose of heroin 
as a means of suicide was infrequently used compared with prescription non-
opiate medication overdose or more violent methods (Darke and Ross 2002). 
 
Perception of risk 
 
In other research into survivors of drug overdose, Darke and Ross (1997) found 
that 80% of survivors of heroin overdose did not perceive themselves at high risk 
of overdose, despite experiencing one in the previous six months and despite 
research indicating that overdose was a common occurrence in heroin users 
(Darke et al 1996).  Zador et al (2001) confirmed this perception of a low 
personal likelihood of a subsequent overdose among heroin users interviewed 
within seven days of their most recent overdose.  Furthermore, only 11% stated 
that they would seek treatment when asked what impact their recent overdose 
would have on their future drug using behaviour.  The majority of individuals 
indicated that they would continue to use heroin albeit more safely, or try to stop. 
 
Other research has shown that although drug users give many reasons for 
seeking treatment (desire to stop using drugs, tired of the heroin-using lifestyle, 
fear of re-incarceration or relationship breakdown), experience of overdose or 
worry about having one was rarely one of these reasons (Weatherburn and Lind 
2001, Sell and Zador 2004). 
 
Recent research has revealed the high prevalence of morbidity in injecting drug 
users both as a cause and consequence of overdose (Warner-Smith et al 2001) 
which indicates the need to emphasise the greater range of health consequences 
of a non-fatal overdose in harm reduction messages to injecting drug users.  The 
offer of intervention e.g. provision of an information card about local agencies and 
services to heroin users at the time of overdose by ambulance officers has been 
shown to be successful at targeting an often ‘hidden population’ of high risk users 
who might not otherwise be in contact with treatment or other services (Dietze et 
al 2002). 
 
This evidence base implies that experience of overdose is neither a deterrent to 
future drug use nor a motivator for seeking treatment.  If overdose is personally 
contextualised as an acceptable “occupational risk” by injecting drug users, along 
with the risk of blood-borne viral infection and incarceration, then this would 
imply a different overdose prevention strategy from that where overdose is 
contextualised as a marker of underlying psychopathology.  The complex 
relationships between experience of drug overdose, perceived risk of overdose, 
depression and suicide need further exploration.  At the very least, research to 
date suggests that future strategies designed to prevent drug overdose need to 
target risk perceptions, knowledge of risk factors for fatal overdose, as well as 
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mental health status and other factors within this high risk group.  However, 
these findings need to be replicated in Scottish drug users. 
 
Aims and Objectives of the Study 
 
Aims 
 
1. To collect and analyse information relating to the clinical and social 
circumstances surrounding all drug-related deaths in Scotland for the period 
January – December 2003. 
2. To identify patterns in social and clinical circumstances surrounding the 
deaths, and the associations between them. 
3. To make recommendations for policy and practice which may lead to a future 
reduction in drug-related deaths. 
Objectives 
 
1. For all individuals: to establish and explore the nature of the individual’s social 
circumstances prior to death including employment and accommodation 
status, social networks and family circumstances, and the nature of the 
individual’s drug use. 
 
2. For all individuals: to determine the specific combinations of drugs associated 
with each death: to analyse patterns in the toxicology reports on each death, 
to determine the involvement of illicitly-obtained prescription medication, to 
investigate differences between injecting drug users and non-injecting drug 
users in the circumstances of death. 
3. For all individuals: to establish the nature and extent of contact with 
“services” prior to their death. 
 
4. For those individuals who were in contact with “services” prior to death: 
 
• To determine the nature of the individual’s contact.  To determine the 
individuals who had a previous non-fatal overdose, and whether there was 
any follow-up by “services”. 
 
• To determine the individuals who had been released from prison, and 
whether they had been offered, and had participated in the prison 
Transitional Care arrangements. 
 
• To determine the nature of the individual’s contact with the wider criminal 
justice system (e.g., the police and court system). 
 
• To collect detailed data on the care of individuals who had received 
treatment (including a detoxification programme) for drug misuse, to 
compare the clinical care received by those who were in treatment with 
national clinical guidelines, to consider whether there was anything that 
“services” could have done, or could do in the future, to prevent death. 
5. For individuals who were not in contact with services prior to death: to 
identify whether individuals were unknown to “services” or whether there had 
been breakdowns in the care pathways for these individuals, and to determine 
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which, if any, were waiting for drug treatment, and explore the contribution of 
this to their death. 
 
6. On the basis of the information gathered for 1-5 above: to explore the 
possibility of drawing conclusions about regional differences in deaths, and to 
determine whether the circumstances associated with 2003 deaths are 
broadly reflective of what is already known about risk factors from previous 
research. 
 
7. Investigate patterns in broad demographic variables (e.g., gender, age, etc.) 
for the period 1996 – 2003, investigate patterns in gender and age. 
 
In addition, the study includes the following aims: 
   
1. Extended interviews with a sub-sample of living injectors who had survived an 
overdose in the 6 months prior to interview to obtain more information about 
survivors’ beliefs, experience and knowledge of overdose. 
 
2. A comparison of the characteristics of Scottish drug related deaths with a 
sample of London drug deaths for the same year (2003). 
 
Methods 
  
(1) Drug related deaths in Scotland, 2003 
 
The study population comprised 317 cases of drug-related death in 2003 
identified by GROS.  Case definitions of drug related deaths were based on ICD-
10 codes for drug-related death categories (see Appendix 1).  In brief, each case 
of a drug related death as found by the Procurator Fiscal was entered by the 
GROS into one of four main ICD-10 categories: ‘mental and behavioural disorders 
due to psychoactive substance use’ (F11, 13, 19), i.e. accidental drug overdoses 
occurring in persons with drug dependence or abuse, drug-related suicides (X61, 
62), ‘poisoning by narcotics of undetermined intent’ (Y12), and ‘accidental 
poisoning’ (X41). 
 
Prior to commencement of the study, full ethical approval was obtained from the 
MREC Scotland.  The study was conducted within the research governance 
framework for health and community care (SEHD, 2001) and was externally 
audited in February 2005.  NHS Forth Valley acted as research sponsor for the 
investigation. 
 
Before contacting NHS services each local research ethics committee (LREC) was 
informed of the study and management approval to conduct the study was 
obtained from each research and development committee. 
 
The Association of Directors of Social Work (ADSW) standing committee on 
standards, training and research gave formal support to this study in January 
2004. In addition each Director of Service or equivalent was contacted for 
permission prior to approaching individual social work services. 
 
Two standardised data collection forms were developed: The clinical and social 
circumstances (CSC) form was used to record information obtained from case 
notes held with social care services, specialist drug treatment services, mental 
health services, and non-statutory agencies across all health board areas in 
Scotland.  The fiscal file (FF) data collection form recorded data on the 
circumstances of death, post-mortem toxicological findings and cause of death 
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sourced from deceased cases fiscal files, sent down by Procurators Fiscal offices 
to the Crown Office. 
 
Copies of these data collection forms may be obtained from the investigators. 
 
In addition, information was collected from the Scottish Prisons Service (SPS), 
Scottish Criminal Records Office (SCRO), Practitioner Services Division (PSD) and 
Information and Statistics Division (ISD) of the Common Services Agency (SMR 
00 (outpatient attendances), 01 (acute hospital admissions) and 04 (psychiatric 
hospital admissions) databases. 
 
The following variables of information were collected: sociodemographic 
characteristics including accommodation, employment and relationship status, 
circumstances of death and post-mortem toxicology findings, cause of death, 
pattern of contact with health, social and criminal justice agencies in the 6 
months prior to death including reason for, frequency of, and outcome of contact, 
medical and psychiatric history, and drug treatment details, history of non-fatal 
overdose and relevant details of offending history including incarceration. 
 
A team of six data collectors were recruited to the study and trained in the use of 
the data forms and in the interpretation of service case note and fiscal file 
information by three of the investigators (BK and AB, and DZ respectively).  The 
data collectors were under the management and regular supervision of the 
research project manager (AR).  They read files and recorded relevant data onto 
the CSC and FF forms. 
 
A list of all drug services in Scotland was compiled by merging three existing 
databases:  the Corporate Action Plans of the 22 Drug and Alcohol Action Teams, 
the services database of The Centre for Drug Misuse Research, University of 
Glasgow and the Scottish Drugs Forum Directory of Specialist Helping Agencies.  
In addition, all NHS mental health services and local authority social work 
departments were included. 
 
The project manager made initial contact with each agency normally by phone, 
outlining the nature of the investigation and asking for agreement in principle to 
access any records that they might hold.  A letter detailing the aims and 
objectives of the study, relevant permissions and approval and a formal request 
for access to records followed this up.  Once permission had been given the 
geographic catchment area of each service was established and a list of names of 
people who died within that area was provided to them.  This was normally sent 
as a password-protected spreadsheet to a named individual within the agency.  
That person normally chose the password.  On occasion, with the prior knowledge 
and agreement of the named individual, the list of names was posted to an 
agency addressed to that person and marked ‘private and confidential’. 
 
After establishing which people had been known to each service, arrangements 
were made for the data collectors to visit the agency in order to examine the case 
records and extract the data required to complete the CSC form as fully as 
possible. Table 1.1 below sets out the number of agencies contacted in each 
health board area. 
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Table 1.1: Number of agencies contacted in each health board area 
 
Health Board Area NHS Local Authority Non-Statutory 
Argyll & Clyde 6 7 11 
Ayrshire & Arran 3 4 5 
Borders 1 0 0 
Dumfries & Galloway 2 2 2 
Fife 2 3 8 
Forth Valley 3 3 4 
Grampian 4 4 5 
Greater Glasgow 5 15 13 
Highland 2 2 3 
Lanarkshire 5 8 2 
Lothian 3 4 22 
Tayside 4 7 1 
Western Isles 1 0 0 
Scotland 41 59 75 
 
In total 175 services were contacted, of which 173 (99%) gave their permission 
for the data collectors to access their records.  
 
Data recorded on the CSC and FF forms as well as selected data provided by ISD 
were entered into SPSS (v. 12) for quantitative analysis.  These analyses were 
descriptive. 
 
(2) Trends in drug related deaths in Scotland, 1996-2003 
 
Data collected by the General Register Office for Scotland  (GROS) on drug-
related deaths in Scotland during 1996-2003 were examined for trends in all 
deaths and those involving either heroin/morphine or methadone.  Poisson 
regression was used to assess the rate of change in drug-related deaths during 
1996-2003 by cause of death, day of death, gender, age, health-board area and 
drugs specified on the death certificate. 
 
(3) Experiences of overdose survivors 
 
Injecting drug users (IDUs) were interviewed as part of an ongoing study 
evaluating the change in the Lord Advocate’s guidelines on the supply of needle 
and syringes to injecting drug users.  A multiple site recruitment strategy was 
used to generate as representative a sample as possible of IDUs in Glasgow.  
Sites included pharmacy exchanges, needle exchanges, drug treatment services 
and various street sites throughout Glasgow.  Recruitment was undertaken in two 
phases.  The first phase took place between February and April 2004.  The second 
phase began in July 2004 and ended in October 2004. 
 
Criteria for inclusion in the study was having injected a drug in the previous 
month. 
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Interviewers explained the study to all respondents and assured them that all 
information provided by them was anonymous and confidential.  Those who had 
experienced an overdose in the previous 6 months were asked to consent to a 
follow-up interview and asked to provide a contact number and address.  
Interviews took place in a venue chosen by the injector (usually their own home) 
and were audio-taped. 
 
The interviews sought to determine: 
 
• IDUs knowledge of risk factors for overdose 
• IDUs overdose risk behaviours 
• IDUs knowledge of appropriate interventions in overdose situations 
• Why respondents believed they had survived their overdose  
• How overdoses could be prevented 
• If respondents were in treatment at time of overdose 
• If not in treatment, why not 
• IDUs personal perception of overdose risk. 
 
Audio-taped interviews were transcribed and analysed by summarising responses 
and identifying themes.  Quantitative data were entered into SPSS (v.12) for 
analysis. 
 
(4) Comparison of Scottish and London Drug Related Deaths (DRDs) 
 
The Scottish data were extracted from Procurator Fiscal files as described above.  
London coronial data were extracted from 7 of the 8 coronial courts, accounting 
for approximately 75% of drug related deaths in London.  As the GROS criteria 
for identifying cases of drug related deaths were not used in the London study, 
deaths from both samples were selected that were positive on post-mortem 
toxicology for morphine (heroin), methadone, cocaine, MDMA, amphetamines, or 
dihydrocodeine yielding 273 deaths for Scotland and 148 for London.  The 
number of Scottish cases used for this part of the study is lower than the total 
number of deaths investigated in the main report, as deaths not positive for any 
of these drugs were excluded. 
 
All data were entered into SPSS (v.12) for quantitative analysis.  Simple 
descriptive analyses assessed differences between London and Scotland in terms 
of age, gender, toxicology, homelessness, history of imprisonment, drug 
treatment, place of death, number of witnesses and ambulance attendance. 
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What is in this chapter?  This section of the report describes the 
demographic profile of the study population.  It also presents trends in drug 
related deaths in Scotland during 1996-2003. 
 
Where did the information come from?  Demographic data on drug-
related deaths in 2003 and trends in characteristics of drug deaths during 
1996-2003 were sourced from the GROS database.  Deprivation categories 
were available from NHS returns to ISD on 218 of the 317 cases of drug-
related death.  There were 317 drug related deaths in Scotland in 2003 
registered by the General Register Office for Scotland (GROS). 
Chapter 2:  Profile of the study population 
 
 
Cause of death 
 
Cause of death by ICD-10 drug-related death category and gender for the sample 
are set out in Table 2.1.  Definitions of drug-related deaths based on ICD-10 
criteria are provided in Appendix 1. 
 
Table 2.1: Drug related deaths by ICD-10 category and gender (n=317) 
 
ICD-10 Category All (%) Male Female Ratio (M:F) 
Drug abuse 
(F11-F16, F19) 
216 (68) 190 26 7.3:1 
Intentional 
self-poisoning 
(X60-X64) 
40 (13) 24 16 1.5:1 
Accidental 
poisoning 
(X40-X44) 
15 (5) 12 3 4:1 
Undetermined 
(Y10-Y14) 
46 (15) 30 16 1.9:1 
All 317 (100) 256 61 4.2:1 
Source: GROS (2004) 
 
The majority (68%) of cases were considered to have died as a result of ‘drug 
abuse’, i.e. ‘mental and behavioural disorders due to psychoactive substance use’ 
(ICD-10) or (more commonly known as) fatal drug overdose.  Suicides comprised 
13% of the total number of deaths. 
 
Demographics 
  
The demographic characteristics of the population are set out in Table 2.2.  The 
majority of cases were male (81%).  Mean age of the group was 32.7 years, 
range 16 to 82 years).  Over one third of the group (39%) was aged between 25 
and 34 years. 
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Table 2.2: Demographic characteristics of cases of drug related death in 
Scotland in 2003 (n=317) 
 
Characteristic Number (%) 
   
Gender:   
Male 256 (81) 
Female 61 (19) 
   
Age (years):   
Total group 32.7 (mean)  
 31.0 (median)  
 16-82 (range)  
Male 32.1  
 16-82 (range)  
Female 35.1  
 16-68 (range)  
Age bands (years):   
15-24 78 (25) 
25-34 123 (39) 
35-44 80 (25) 
45-54 20 (6.3) 
55-64 11 (3.5) 
65+ 5 (1.6) 
 
 
Day of death 
 
Table 2.3 shows the distribution of drug deaths by day of death.  One third (35%) 
died on a weekend day. 
 
Table 2.3: Drug related deaths by day of week (n=317) 
 
Day of week of death: Number (%) 
Monday 36 (11.4) 
Tuesday 35 (11.0) 
Wednesday 41 (12.9) 
Thursday 45 (14.2) 
Friday 48 (15.1) 
Saturday 63 (19.9) 
Sunday 49 (15.5) 
   
 
 
Social deprivation 
 
The Carstairs index (Carstairs and Morris 1991) for social deprivation classifies 
postcode areas on a scale of one to seven with 1 being the most affluent areas of 
the country and 7 being those most socially deprived.  Deprivation categories 
(depcats) of cases of drug related death (n=218; excludes cases with unknown 
depcat scores) were compared with those for the general population (in 
parentheses) in Scotland (Table 2.4). 
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Table 2.4: Percentage of drug-related deaths (n=2181) and of general 
population, Scotland by deprivation category 
 
1 Excludes 99 (31%) cases of drug related death whose depcat scores were unknown 
2One death of unknown depcat therefore excluded from this analysis 
 
 
 
For most health board areas, distribution of drug deaths by depcat score broadly 
reflected the general population’s distribution.  Of note Greater Glasgow was the 
only area to have more than half its total percentage of drug deaths in the most 
deprived category (category 7) – this finding reflected the high proportion of the 
local general population in the same category.  Nationally, there was a lower 
proportion of drug related deaths in the most affluent regions (categories 1 and 
2) compared with the general population (6.5% vs. 20%) and a higher proportion 
 Deprivation Category (DEPCAT) 
Health Board  1 2 3 4 5 6 7 
TOTAL                       % DRDs  
                (% general populn) 
0.5 
(6) 
6 
(14) 
12 
(22) 
24 
(25) 
15 
(15) 
18 
(11) 
24 
(7) 
Argyll & Clyde  0  
(4) 
5 
 (12) 
5 
 (18) 
23 
 (20) 
9 
 (25) 
46 
 (16) 
14 
 (5) 
Ayrshire & Arran  0  
(2) 
0 
 (8) 
7 
 (18) 
36 
 (26) 
43 
 (24) 
14 
 (22) 
0 
 (0) 
Borders  0 
 (7) 
0 
 (11) 
100 
(45) 
0 
 (31) 
0  
(6) 
0  
(0) 
0 
 (0) 
Dumfries & Galloway  0 
 (0) 
13 
 (9) 
13 
 (40) 
50 
 (32) 
13 
 (0) 
13 
 (19) 
0  
(0) 
Fife  0 
  (4) 
0 
 (13) 
38 
 (24) 
63 
 (33) 
0 
 (17) 
0 
 (6) 
0 
 (2) 
Forth Valley  0  
(4) 
10 
 (22) 
10  
(13) 
20  
(41) 
40 
 (18) 
10 
 (2) 
10 
 (0) 
Grampian  0 
 (18) 
29 
 (26) 
13 
 (26) 
38 
 (22) 
21 
(4) 
0 
 (6) 
0 
 (0) 
Greater Glasgow 0 
 (5) 
3 
 (12) 
6 
 (9) 
11 
 (16) 
3 
 (10) 
20 
 (18) 
58 
(30) 
Highland  0 
 (0) 
0 
 (9) 
50 
 (45) 
50 
 (38) 
0  
(8) 
0 
 (0) 
0 
 (0) 
Lanarkshire  6 
 (1) 
0  
(4) 
18 
 (21) 
12 
 (30) 
18 
 (26) 
35 
 (16) 
12 
 (2) 
Lothian  0 
 (9) 
7 
 (16) 
14 
 (20) 
29 
 (30) 
25 
 (17) 
7 
 (5) 
18 
 (3) 
Orkney  0  
(0) 
0  
(0) 
0  
(100) 
0  
(0) 
0  
(0) 
0  
(0) 
0  
(0) 
Shetland 0 
(0) 
0  
(0) 
0 
 (62) 
0  
(38) 
0  
(0) 
0  
(0) 
0  
(0) 
Tayside   0 
 (8) 
0   
(21) 
18 
 (29) 
27 
 (10) 
27 
 (11) 
27  
(15) 
0  
(7) 
Western Isles2 0  
(0) 
0 
 (0) 
0  
(40) 
0  
(55) 
0  
(4) 
0  
(0) 
0  
(0) 
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of cases (42% vs. 18%) in the most deprived regions (categories 6 and 7).  
However, it must be noted that in 31% of drug related deaths, deprivation 
category was unknown. 
 
Trends in and characteristics of drug-related deaths in Scotland, 
1996-2003 
 
The majority of the 2,331 drug-related deaths recorded in Scotland during 1996-
2003 were aged 15-54 years (96%: 2,240/2,331).  Restricting to this age group, 
drug-related deaths in Scotland increased from 234 in 1996 to 301 in 2003.  
Three out of four deaths involved either heroin/morphine (1,209; 54%) or 
methadone (620; 28%).  Figure 2.1 shows the trends in heroin/morphine, 
methadone and other drug–related deaths in Scotland during 1996-2003.  Deaths 
involving heroin/morphine increased two-fold from 82 in 1996 to 164 in 2003 
(representing a 13.8% yearly increase), whereas those involving methadone 
reduced from 99 in 1996 to 55 in 1999 and 86 in 2003 (representing a 0.4% 
yearly decrease).  Other drug-related deaths (i.e. those without heroin/morphine 
or methadone detected) remained relatively stable, with a 3% yearly increase, 
during 1996-2003. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tables A2.1 – A2.3 (Appendix 2) show the characteristics of and the annual 
change in (a) all drug-related, (b) heroin/morphine-related and (c) methadone-
related deaths among persons aged 15-54 years in Scotland during 1996-2003.  
The majority (79%) of all drug-related deaths were considered to have died from 
either drug abuse or accidental poisoning, 9% from intentional self-poisoning and 
12% were undetermined as to accidental or intentional.  A significantly higher 
proportion of methadone (55%) compared to heroin/morphine (45%) related 
deaths occurred at the weekend, defined as Friday, Saturday or Sunday; 
1996 1998 2000 2002 
0 
50 
100 
150 
200 
250 Heroin/morphine-related deaths (incl. deaths involving methadone) 
Methadone-related deaths (includes deaths involving heroin) 
Other drug-related deaths (i.e. unrelated to heroin/morphine or 
methadone) 
No. of  
drug-
related  
deaths 
Figure 2.5:  Trends in heroin/morphine, methadone and other drug -
related deaths among persons aged 15-54 years in Scotland, 1996-2003 
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although, the number of deaths at the weekend involving methadone have 
decreased during 1996-2003 by 3.5% per year.  The annual number of drug-
related deaths increased at a significantly higher rate among persons aged 35-54 
years compared to those aged 15-24 years (16.0% vs 0.3% yearly increase, 
respectively). 
 
The annual increase in all drug-related deaths was higher in health-board areas 
(except for Lothian and Tayside) outwith Glasgow.  In Lothian and Tayside, 
approximately half of drug-related deaths involved methadone, although these 
deaths reduced by 11.2% and 19.3% per year, respectively, during 1996-2003 
(Table A2c).  The annual increase in heroin/morphine-related deaths was 
significantly higher in other health-board areas (except Lothian) compared to 
Glasgow; the percentage of heroin/morphine-related deaths in Glasgow reduced 
from 70% in 1996 to 37% in 2003.  A substantial proportion (57%) of drug-
related deaths involved benzodiazepines and 38% involved alcohol.  The number 
of drug-related deaths involving cocaine, although only representing 5% of the 
total, increased from 3 in 1996 to 28 in 2003.  
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Key points 
 
 
• Most Scottish drug related deaths in 2003 were male, and in their early 30s 
(mean age of 32.7 years). 
• The majority (68%) of drug related deaths in Scotland were accidental fatal 
overdoses.  Suicides comprised 13% of the total. 
• Trends in drug related deaths in Scotland from 1996 to 2003 were complex 
and showed a great deal of heterogeneity over time in relation to geographical 
distribution and the involvement of heroin/morphine or methadone. 
• Drug-related deaths involving heroin/morphine had increased at a significantly 
higher rate than those involving methadone in Scotland during 1996-2003 
(13.8% vs –0.4% per year, respectively).  In Glasgow however, deaths 
involving methadone increased at a higher rate (average 9.7% per year) than 
deaths involving heroin (which increased at an average 6.5% per year). 
• Drug-related deaths involving heroin/morphine had increased at a significantly 
higher rate out-with the main urban centres of Glasgow and Lothian during 
1996-2003.  Overall, there were twice as many deaths involving 
heroin/morphine as methadone.  However, the ratio of heroin/morphine : 
methadone overdose deaths varied considerably between geographical 
areas:- for example, from 117 : 26 in Lanarkshire to 21 : 70 in Tayside and 
59 : 175 in Lothian. 
• A higher proportion of methadone compared to heroin/morphine –related 
deaths in Scotland occurred at the weekend (defined as Friday to Sunday).   
Drug-related deaths in Scotland, including those involving either 
heroin/morphine or methadone, have increased at a significantly higher rate 
among those aged 35-54 compared to 15-24 years during 1996-2003. 
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What is in this chapter?  This section describes the circumstances of death 
and toxicological findings of the sample of drug-related deaths, and 
determines the involvement of illicitly-obtained prescription medication.  It 
also investigates toxicological differences between injecting drug users and 
non-injecting drug users, and compares characteristics of the Scottish sample 
of drug deaths with those of a group of drug related deaths in London for the 
same year. 
 
Where did the information come from?  The findings presented in this 
section on toxicology and circumstances of death are based on data extracted 
from the fiscal files for the 317 cases of drug related death.  Seventeen (17) 
files were unavailable either because of ongoing criminal proceedings or 
because some were destroyed by fire at one of the Procurator Fiscal offices.  
Therefore these cases were excluded from the analysis, leaving a sample size 
of 300 cases. 
 
London coronial data were extracted from seven of the 8 coronial courts, 
accounting for approximately 75% of drug related deaths in London.  As the 
GROS criteria for identifying cases of drug related deaths were not used in the 
London study, deaths from both samples were selected that were positive on 
post-mortem toxicology for morphine (heroin), methadone, cocaine, MDMA, 
amphetamines, or dihydrocodeine, yielding 273 in Scotland and 148 deaths in 
London.  The number of Scottish cases used for this part of the study is lower 
than the total number of deaths investigated in the main report as deaths not 
positive for any of these drugs were excluded. 
 
Chapter 3:  Toxicological findings and circumstances of   
 death 
 
 
Social and drug-using characteristics of cases of drug-related 
death  
 
The social circumstances at the time of death for the study population are shown 
in Table 3.1.  The majority (81%) of cases were living at home in a house or flat 
when they died.  Few were noted as street homeless in the fiscal files (<2%) 
although another 35 cases (12%) were in temporary housing at the time of their 
deaths.  Just over half (58%) were living with others, although not necessarily in 
a relationship.  Thirty-six per cent (36%) of cases were single. 
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Table 3.1: Social and drug-using history characteristics of cases of drug-
related death (n=300) 
 
Characteristic Number (%) 
   
Accommodation (at time 
of death): 
  
House/flat 244 (81.3) 
Hostel 24 (8.0) 
‘Sofa surfer’ 11 (3.7) 
Hotel room 8 (2.7) 
Street homeless 5 (1.7) 
Campervan/car 2 (0.7) 
Unknown 6 (2.0) 
   
Living arrangements (at 
time of death): 
  
Living with others 175 (58.3) 
Living alone 110 (36.7) 
Other 4 (1.3) 
Unknown 11 (3.7) 
   
Relationship status (at 
time of death): 
  
Single 109 (36.3) 
In a relationship 98 (32.7) 
Unknown 93 (31.0) 
   
Pattern of drug use:   
Dependent 228 (76.0) 
Recreational 15 (5.0) 
First time (‘novice’) 2 (0.7) 
Unknown 55 (18.3) 
   
Known IV drug user:   
Yes 145 (48.3) 
No 89 (29.7) 
Unknown 66 (22.0) 
 
 
The majority of cases were dependent drug users (76%) and nearly half (48%) 
were known to be injecting drug users at some time in their drug-using careers. 
 
Circumstances of death  
 
In nearly half (48%) of cases, others were present in the vicinity of the overdose 
event, usually a friend or partner (Table 3.2).  Deaths occurred in a home 
environment (68%), either in their own home or in a friend’s place.  Period of 
time elapsed between overdose and death for most cases was several hours or 
more (50%) or within an hour (14%), and indicates that there was potential 
opportunity for intervention.  Drugs were injected at the time of death in 46% of 
cases. 
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Table 3.2: Circumstances of death (n=300) 
 
Characteristic Number (%) 
   
Number of cases where 
others present 
145 (48.3) 
   
Type of witness present*:   
Friend 68 (46.9)** 
Partner 46 (31.7) 
Family member 29 (20.0) 
Other 13 (9.0) 
Unknown 3 (2.1) 
   
Place of death:   
Own home 145 (48.3) 
Friend’s home 60 (20.0) 
Hospital 30 (10.0) 
Hostel 19 (6.3) 
Family member’s home 17 (5.7) 
Hotel/motel 7 (2.3) 
Other 21 (7.0) 
Unable to be determined 1 (0.3) 
   
Period of time between 
overdose and death: 
  
‘Instant’ 25 (8.3) 
Within the hour 43 (14.3) 
Several hours 136 (45.3) 
12 hours or more 11 (3.7) 
Several days 4 (1.3) 
Not seen for a time and 
found dead 
31 (10.3) 
Unable to be determined 50 (16.7) 
   
Drugs/paraphernalia 
present at the scene: 
  
Yes 197 (65.7) 
No 93 (31.0) 
Unknown 10 (3.3) 
   
Route of administration 
of ‘fatal’ dose# 
  
Injection 137 (45.7) 
Non-injection 131 (43.7) 
Unknown 32 (10.7) 
* Total number of witnesses present exceeds total number of cases where 
   witness present because some cases had more than one witness at the scene 
**For this variable, numbers were expressed as percentage of total number of cases where witness 
present (n=145) 
#  A case was defined as an injector if the route of administration of one or more drugs prior to death  
included injection. Cases considered to have died from a combination of routes e.g. injection of heroin 
with oral consumption of diazepam and alcohol were classified as injectors. Non-injectors comprised 
all cases not defined as injectors i.e. cases who died after ingestion of drugs by oral, smoked and/or 
snorted routes. A case was classified ‘unknown’ if the route of administration was unable to be 
determined from the available information within the file. 
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Interventions attempted at the scene  
 
Of cases where a witness was present (n=145), the most frequent intervention 
attempted was cardio-pulmonary resuscitation (CPR) (64, 44%), followed by 
various combinations of slapping, using cold water or showering (31, 21%).  
However, no intervention was attempted by those present in nearly 40% of 
cases.  At some (unrecorded) point in time after the overdose became known to 
others, an ambulance was called to the scene in 82% of cases.  Of calls made to 
the ambulance by witnesses, most were made by friends or family (78% of 247).  
Nevertheless, in 81% of cases it was too late, the person being identified as dead 
on arrival by the ambulance crew.  These data are set out in Table 3.3. 
 
Police were in attendance at 90% of the scenes of the overdose following a call, in 
most cases where it was known, from either the ambulance service (18%), or a 
friend or acquaintance (16%).  In 48% of cases however, it was not clear who 
had notified the police.  At the scene, the police undertook no activity in 87% of 
cases, in 5% of cases they were called to obtain access to the overdosed person 
e.g. force entry through a locked door, and in 10 cases police performed CPR. (In 
October 2003 a Memorandum of Understanding was developed and implemented 
between the police and ambulance services which states that the police should be 
called to attend all cases where the use of illicit drugs is known or suspected). 
 
Table 3.3: Interventions attempted (n=300) 
 
Characteristic Number (%) 
Interventions attempted by witnesses (n=145):   
None 55 (37.9) 
CPR 64 (44.1) 
Move to coma position 9 (6.2) 
Other (slapping, cold water, shower) 31 (21.4) 
   
Ambulance called to scene:   
 Yes 247 (82.3) 
 No 53 17.7) 
   
Who called ambulance(n=247):   
Friend/family 192 (77.7) 
Worker/staff member 26 (10.5) 
Police 13 (5.3) 
Other 7 (2.8) 
Unknown 9 (3.6) 
   
Deceased already dead on ambulance’s arrival (n=247):   
Yes 201 (81.4) 
No 37 (15.0) 
Unknown 9 (3.6) 
   
Police in attendance:    
Yes 271 (90.3) 
No 29 (9.7) 
   
Who called police:   
Ambulance 53 (17.7) 
Friend 49 (16.3) 
Family 17 (5.7) 
Worker/staff 15 (5.0) 
Other 23 (7.7) 
Not known 143 (47.7) 
   
Interventions by police:   
None 262 (87.3) 
Obtain access to person 15 (5.0) 
CPR 10 (3.3) 
Other 12 (4.0) 
Moved to coma position 1 (0.3) 
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These findings indicate a period of delay during which no intervention was 
undertaken by witnesses before contact with ambulance services was made.  Of 
those witnesses who tried to resuscitate the person before the arrival of the 
ambulance, CPR was more frequently attempted than slapping the victim or other 
intervention, however it was utilised in less than half of cases. 
 
Toxicological findings 
  
Results of post-mortem drug testing for the sample are set out in Table 3.4. 
 
Table 3.4: Drugs detected at post-mortem (n=2951) 
 
Positive cases Drug 
Number (%) 
BZDs (total)2 202 (68.5) 
      Diazepam 171 (58.0) 
      Temazepam 85 (28.8) 
      Oxazepam 47 (15.9) 
     Other BZD  10 (3.4) 
Heroin/morphine 178 (60.3) 
Alcohol 167 (56.6) 
Codeine3 134 (45.4) 
Methadone 83 (28.1) 
Dihydrocodeine 51 (17.3) 
Cannabis4 31 (10.5) 
Antidepressants5 31 (10.5) 
Paracetamol 29 (9.8) 
Cocaine 27 (9.2) 
MDMA (ecstasy) 16 (5.4) 
Amphetamines 11 (3.7) 
Other6 34 (11.5) 
   
1. Data are missing in 5 cases 
2. Includes all cases positive for one or more benzodiazepines (BZDs). 
3. While codeine was also frequently detected (45%), it appeared in the absence of heroin/morphine 
in only 18 counts (13%) of codeine positive cases.  This could mean (more likely) that codeine is 
a marker for street heroin or that ingested codeine has been partially metabolised to morphine. 
4. Number of cases may be an underestimate as cannabis is not routinely included in post-mortem 
toxicological analysis 
5. Includes tricyclics (n=16), SSRIs (n=14) and SNRIs (n=1). 
6. Includes antipsychotics (n=4), ibuprofen (n=7), carbamazepine (n=4), propoxyphene (n=3), 
tramadol (n=3), zopiclone (n=2), phenobarbitone (n=3), others (n=8).  
 
 
Table 3.4 shows that heroin/morphine (60%) and diazepam (58%) were the two 
most frequently detected drugs in cases of drug-related death in Scotland in 
2003.  However, if individual benzodiazepines are grouped together as a class (as 
is typically done in published studies of toxicological findings of drug-related 
deaths in order to avoid attempting to distinguish between different orally 
ingested benzodiazepines, and metabolites of diazepam), then benzodiazepines 
were the most commonly detected drugs in this sample (69% of all cases).  
Diazepam alone accounted for 85% of all BZDs detected.  Alcohol was the only 
other drug detected in more than half (57%) of the sample.  Methadone was 
detected in just over a quarter (28%) of drug deaths. 
 
Cocaine was present in less than 10% of cases indicating that this drug featured 
in a relatively low proportion of cases in Scotland in 2003 as did other 
psychostimulant drugs (amphetamines, MDMA). 
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It is important to appreciate that Table 2.4 contains information only on drugs 
detected at post-mortem based on data sourced from forensic laboratory 
toxicology reports, and is not a count of drugs implicated in the cause of death.  
This is probably why counts for some drugs e.g. diazepam, temazepam and 
alcohol are somewhat higher than the figures reported in the ‘selected drugs 
involved’ table in the GROS annual drug-related deaths report for 2003 (GROS 
2004) which are compiled from submitted cause of death information, other 
information supplied by procurators fiscal and information obtained from 
confidential forms (voluntarily) sent in by forensic pathologists (personal 
communication, Graham Jackson, GROS, 2005). 
 
Toxicological differences between injectors and non-injectors 
 
The 300 cases comprised 137 injectors (46%), 131 non-injectors (44%) and 32 
cases (11%) where route of administration was unknown.  The unknown group 
was excluded from further analysis leaving a remaining sample of 268 cases. 
Fifty-nine per cent (59%) of males (n=211) and 23% of females (n=57) were 
injectors (p<.001).  Injectors and non-injectors were compared to examine 
differences in toxicology, if any, between the two groups.  Results of this analysis 
are set out in Table 3.5. 
 
Table 3.5: Drugs detected by injector status (n=268)1 
 
Drug  Injector 
(n=137) 
Non-injector 
(n=131) 
   
BZDs  91 (66.4%) 92 (70.2%) 
Heroin/morphine  131 (95.6%) 28 (21.4%)* 
Alcohol  79 (57.7%) 73 (55.7%) 
Codeine2 99 (72.3%) 26 (19.8%)* 
Methadone 15 (10.9%) 57 (43.5%)* 
Dihydrocodeine 12 (8.8%) 34 (26.0%)* 
Cannabis  9 (6.6%) 18 (13.7%) 
Anti-depressants 4 (2.9%) 24 (18.3%)* 
Paracetamol  8 (5.8%) 17 (13.0%) 
Cocaine 14 (10.2%) 9 (6.9%) 
MDMA (ecstasy) 5 (3.6%) 9 (6.9%) 
Amphetamines 3 (2.2%) 4 (3.1%) 
Missing data 1 (0.7%) 1 (0.8%) 
   
132 cases with unknown injecting status were excluded from this analysis. 
2 see footnote 3, Table 3.4 in this chapter. 
*Statistically significant difference between groups (chi-square, p<.001) 
 
 
Injectors were statistically significantly more likely to be positive for 
heroin/morphine and codeine while non-injectors were significantly more likely to 
be positive for methadone, dihydrocodeine and anti-depressants.  
 
Combinations of drugs  
 
Few cases (5.4%) were positive for only one drug at post-mortem.  One case was 
positive for heroin/morphine only, and eight more were positive for 
heroin/morphine and codeine only.  As codeine in the presence of morphine is 
likely to be a marker for street heroin, these eight cases have been combined 
with the case positive for heroin for a total of nine heroin/morphine only cases.  
There were three cases positive for methadone only, one case positive for 
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benzodiazepines only, one case for alcohol, one case for cocaine, and one case for 
MDMA (although this case was also positive for gabapentin, an anti-epileptic 
drug).  The vast majority (95%) of cases were cases of poly-drug use. 
  
Poly-drug cases were analysed by types of detected drug combinations.  Among 
the 295 cases for which toxicology results were available, there were a total of 
126 different combinations of drugs detected.  The seven most frequently 
occurring drug combinations are set out in Table 3.6. 
 
Table 3.6: Most frequent combinations of drugs detected (n=295) 
 
Drug combination1 Number of cases (%) 
     
HmBzd(Cod) 312 (10.5) 
HmAlc(Cod) 303 (10.2) 
HmAlcBzd(Cod) 284 (9.5) 
MethAlcBzd 165 (5.4) 
MethBzd 12 (4.1) 
HmAlcBzd 6 (2.0) 
AlcBzdDhc 5 (1.7) 
   
1Hm=heroin/morphine, Alc=alcohol, Bzd=benzodiazepines, Cod=codeine, Dhc=dihydrocodeine,  
 Meth=methadone 
2 Includes 22 cases positive for codeine 
3Includes 16 cases positive for codeine 
4Includes 22 cases positive for codeine 
5Includes 5 cases also positive for cannabis. 
 
This shows that heroin/morphine was included in four (57%) of the seven most 
frequently occurring drug combinations detected.  However, benzodiazepines and 
alcohol (both usually orally consumed drugs) featured more frequently, i.e. in six, 
and in five, respectively, of the seven most common drug combinations.  Overall, 
36% of deaths (n=107) involved a combination of only orally ingested drugs. 
 
Prescribed drugs 
 
Methadone had been prescribed for 52% of 83 cases found positive for the drug 
at post-mortem  This left nearly half of methadone-positive cases not in receipt of 
a prescription at time of death i.e. individuals who probably acquired and ingested 
an illicit source of methadone prior to death.  Similarly, diazepam had been 
prescribed for only 31% of 171 cases found positive for diazepam, leaving two-
thirds of positive cases that were not apparently prescribed the drug, and 
dihydrocodeine was prescribed to only 35% of 51 cases positive for the drug.  
This suggests that either illicit manufacture and/or diversion of prescribed drugs 
is a substantial source of drugs for users, and remains a significant issue for 
health service providers and others in the field. 
 
Blood drug concentrations 
 
The mean (median) blood morphine concentration was 0.269 mg/L (0.200 mg/L) 
(n=176) with a range of 0.006 – 3.360 mg/L, and the mean (median) blood 
methadone concentration was 0.517 mg/L (0.309 mg/L) (n=80) with a range of 
0.014 – 2.6 mg/L.  Ranges of 0.05 - 0.15 mg/L or 0.15 - 0.5 mg/L for morphine, 
and 0.2 mg/L or higher for methadone are often referred to by forensic toxicology 
laboratories as ‘fatal’ levels (personal communication, Lothian and Borders Police  
Forensic Laboratories, Edinburgh, 2005), and mean values reported in this study 
fell within these ranges.  Forty-one per cent of morphine-positive deaths had 
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morphine values below the ‘fatal’ level of 0.15 mg/L and 29% of methadone 
positive deaths had methadone values below the ‘fatal’ level of 0.2 mg/L.  The 
pattern of distribution of these blood concentration levels (see Figures A3.1 and 
A3.2 in Appendix 3) continues to raise questions about the clinical utility of 
designated ‘fatal’ levels. 
 
Mean (median) blood alcohol concentration for the group was 119.6 mg/100mL 
(104.0 mg/100mL) (n=153) with a range of 0.01 – 384.0 mg/100mL.  The 
distribution of values is shown in Appendix 3 (Figure A3.3). 
 
Cause of death findings 
 
‘Opiate intoxication’ was the single most common (131, 44%) cause of death 
recorded on the death certificate, and is consistent with the finding that F11.2 
(opioid dependence syndrome) was the most common ICD-10 code (158, 53%) 
assigned by GROS to cases of drug-related death in the sample.  Also broadly 
consistent with the finding that heroin/morphine, benzodiazepines and alcohol 
were the most frequently detected drugs at death, was the finding that the 
second and third most common causes of death were ‘opiate and alcohol 
intoxication’ (36, 12%) and ‘opiate and benzodiazepine intoxication’ (21, 7%). 
 
However, alcohol, opiate and benzodiazepine related causes of death were also 
variously recorded on the death certificate as ‘opiate and sedative intoxication’ (1, 
0.3%), ‘opiate and tranquilliser intoxication’ (1, 0.3%), ‘anxiolytic and opiate 
intoxication’ (2, 0.7%), ‘anxiolytic, benzodiazepine and opiate drug abuse’ (1, 
0.3%), ‘presumed heroin and alcohol abuse’ (1, 0.3%), ‘presumed acute heroin 
abuse’ (1, 0.3%), ‘narcotic intoxication’ (1, 0.3%), and ‘heroin abuse’ (1, 0.3%). 
 
Of the 131 causes of death described as ‘opiate intoxication’, examination of the 
toxicological findings for this subsample showed that in only 12 (9%) of these 
cases did detected drugs comprise only opiates – in the vast majority of cases, 
toxicology identified other drugs in addition to opiates, most frequently 
benzodiazepines and alcohol.  This suggests either under-reporting on the death 
certificate of other drugs detected or that other drugs detected were not 
considered to be implicated in the cause of death. 
 
In a number of cases the ‘drug’ was not specified on the certificate e.g. 
‘presumed drug and alcohol toxicity’ (2, 0.7%), ‘chronic drug abuse’ (1, 0.3%), 
‘injecting drug abuse’ (1, 0.3%), ‘drugs related death’ (5, 1.7%), ‘mixed drug 
abuse’ (1, 0.3%), and ‘overdose of alcohol and drugs’ (1, 0.3%), even though 
toxicological analysis for each of these cases identified individual drugs present. 
  
Comparison between Scotland and London drug related deaths 
 
Table A3.4 (Appendix 3) sets out the results of the comparison of characteristics 
between the Scottish and London samples of drug related deaths. 
 
In both Scotland and London over half of the deaths were aged over 30, while the 
average age at death was slightly younger in Scotland.  There were no differences 
between Scotland and London by sex, or detection of morphine (heroin), 
methadone, alcohol, or MDMA/amphetamine.  Thus, over 80% of the deaths were 
male with approximately 2/3s of deaths positive on post-mortem toxicology for 
heroin, half positive for alcohol, and 30% methadone.  There was evidence of a 
substitute prescription for over ¼ of the deaths in Scotland and London, and over 
half of the deaths with a positive toxicology for methadone were being prescribed 
it at the time of death.  There were significant differences, however, in terms of 
the proportion of deaths positive for cocaine metabolites, benzodiazepines and 
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dihydrocodeine, prescription - that may reflect different patterns of drug use and 
treatment between the sites.  In London, over 40% of deaths were positive for 
cocaine (most through crack use) compared to 10% in Scotland.  In Scotland, 
proportionally more deaths were positive for benzodiazepines and dihydrocodeine. 
 
The mean blood morphine and methadone concentrations were significantly lower 
in Scotland compared to London.  It is unclear whether this reflects a true 
difference in consumption patterns and prescription dosage, or differences in the 
toxicological testing between the sites.  Mean alcohol concentration was higher in 
the Scottish sample, but did not explain any difference in the mean heroin 
concentration between Scotland and London. 
There were differences in the prison history prior to death between London and 
Scotland.  The London study suggested that 40% of the deaths had a prison 
history compared to 47% in Scotland.  However, 17% of the deaths in Scotland 
were released from prison within 3 months prior to death compared to 10% in 
London.  Part of the difference may possibly be explained by differences in 
services provision between the two sites. The larger proportion of deaths with a 
recent prison history in Scotland, which is a recognised risk factor for drug related 
mortality, is worthy of further investigation. 
There was no difference in the proportion of deaths with evidence of a history of 
injecting, though a small significant difference in the proportion of deaths where 
the most recent dose was ascribed to injecting.  
Deaths in Scotland were less likely to have a witness (48% vs. 61%), which may 
explain why an ambulance was called in a lower proportion of deaths (81% vs. 
91%).  In both Scotland and London, over 80% of the subjects were dead on 
arrival of the ambulance (if it was called). 
 
Cases of drug related death in Scotland were more likely to live in their own 
house or flat compared to London (82% vs. 68%), though the place of death was 
similar with the majority of deaths occurring in the subjects own home or at 
family or friends home, and comparatively few deaths occurring in public spaces 
(10, 3.7% vs. 11, 7.4%).  In both sites, few deaths were determined to have 
occurred instantaneously (9.3% vs. 6.8%); London had a greater proportion of 
deaths where the time between last consumption of drugs and death was 
unknown (26% vs. 53%). 
 
Finally, in order to monitor and inform prevention activities it will be important to 
extend the work to compare the risk of death within Scotland and between the 
sites i.e. what evidence is there that problem drug users in Scotland have a 
similar, higher or lower mortality rate than problem drug users in London or 
elsewhere?  In part this can be accomplished by combining mortality statistics 
with prevalence estimates, but ultimately requires periodic mortality cohort 
studies. 
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Key points 
 
 
• There was potential opportunity to intervene and save the lives of these cases 
of overdose but it was not taken up in many cases. That most cases had died 
by the time the ambulance arrived and that intervention, when attempted by 
others, involved CPR in less than half of cases where a witness was present is 
a matter of concern and a training and education issue for drug users. The 
persistent practice of attempting to resuscitate overdose cases by infliction of 
pain such as cold water or slapping, is an especial matter of concern.  
 
• Benzodiazepines were the single most commonly detected class of drugs at 
post-mortem.  In general, the predominant drugs found ‘on board’ at the time 
of death continue to be heroin/morphine, benzodiazepines and alcohol in 
Scotland. Few cases were positive for psychostimulants, in particular cocaine. 
 
• A relatively high proportion of cases did not inject any drugs prior to overdose 
and death. A high proportion were also positive on toxicological analysis for 
only orally consumed drugs. 
 
• Nearly half of methadone related deaths, and two-thirds of diazepam and 
dihydrocodeine positive deaths involved illicitly obtained sources of these 
medications.  
 
• The same drug-related cause of death may be recorded on the death 
certificate by forensic authorities in various ways. In many cases, toxicology 
identified drugs other than those noted on the death certificate 
 
• Some of the key characteristics of drug related deaths were similar between 
Scotland and London (and share similarities with audits of drug-related deaths 
worldwide). For instance:- 
 
       - 80% were male 
       - Half were over 30  
       - 2/3s involved heroin 
       - 30% methadone 
       - Vast majority involved poly-drugs with alcohol present in over half 
       - Few deaths occurred instantaneously 
       - Most occurred in the subjects’ own home or the home of family or friend 
       - When an ambulance was called most cases were dead on arrival 
 
• In Scotland and London about ¼ of cases were on a substitution prescription, 
and over half of cases with a positive toxicology for methadone were in receipt 
of a prescription.  
 
• In Scotland, a higher proportion of deaths were associated with recent prison 
release (17% vs. 10%). 
 
• Other key differences  include:- 
 
         - Higher number of deaths positive for dihydrocodeine and benzodiazepines 
           in Scotland, and higher number of deaths positive for cocaine in London 
         - Higher number of deaths in receipt of dihydrocodeine substitute 
           prescription in Scotland 
         - Lower average blood concentration of methadone and morphine in 
           Scotland. 
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What is in this chapter?  This section contains information on the social 
circumstances and living arrangements of all people for whom data were 
available within health, social work and independent sector case records 
covering the six months prior to their deaths.  The purpose of this chapter is 
to try to understand the social context within which these individuals 
functioned as part of their community – their personal characteristics; where 
they lived and with whom; how they spent their time; whether they had 
experienced particular life difficulties in the period prior to death.  This 
information could help identify risk factors which may have impacted on the 
circumstances of their death or advise on those areas of the family or 
community in which an intervention might reduce the negative impact of the 
event. 
 
Where did the information come from?  Data were drawn from two 
different sources in order to build as full a picture as possible. 
1. Information was extracted from all available case records (health, social 
work and independent sector) relating to the 237 people who had been in 
contact with services in the six months prior to a drug-related death in 2003. 
2. Information on occupation, relationships, contact with family and friends 
was drawn from the 300 files obtained from the offices of the Procurator 
Fiscal. 
When necessary, data from the different sources have been described 
together to add to the richness of the available information. 
 
Chapter 4:  Social circumstances in the 6 months prior to 
death 
 
Introduction 
 
Obtaining information from personal case records should help to individualise 
these deaths, giving us a unique opportunity to create a more detailed 
psychological and social profile of all individuals that have been categorised as 
dying in drug-related circumstances in Scotland in 2003.  This process also gives 
an opportunity to understand the quality of information that services gather, as 
part of normal practice, on those who attend health and social care services. 
 
The individual, their family and social supports 
 
Elements of this information, mainly contained within fiscal files, have been 
presented in a previous section of this report.  This chapter will describe 
information gathered from all available health, social work and independent 
sector case files for those 237 people who had attended services in the six 
months prior to their deaths. 
 
The individual 
 
Of those 237 people in contact with services during the six months prior to death, 
information on ethnicity was available for 117.  Of these, 114 (97%) were 
described as “white”.  The remainder were from minority ethnic groups.  Of 300 
fiscal files, 190 cases identified ethnicity. All were described as “white”. 
 
Information on educational attainment is available for 123 people (52%).  Of the 
123, 49 left school before the age of 16 years (40%), 59 left at 16 years (48%) 
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Case study  
A male retired divorcee living alone in his own residence on sickness benefits.  
There is no history of polysubstance misuse or offending.  He has a lifetime 
history involving numerous deliberate attempts to overdose with the last 
occurring over 10 years ago.  These had resulted in brief involvement with 
psychiatric services.  He has never received a formal psychiatric diagnosis but 
records show a history of anxiety and depression.  There is also a history of 
chronic back pain of unknown aetiology for over 20 years, resulting in 
retirement through ill health.  His general practitioner prescribed opioid 
analgesia (including morphine), benzodiazepines and anti-depressants.  He 
died of acute morphine poisoning and appears to have taken a deliberate 
overdose of his prescribed morphine tablets. 
This is a case of an atypical gentleman who presented with chronic pain and 
possible dependence associated with his chronic opioid medication and 
psychological problems.  Several factors can be identified which may have 
predisposed this gentleman to take a deliberate overdose but there are no 
obvious precipitating events or circumstances prior to death.  
and 15 left at 17/18 years (12%).  There was no information on qualifications 
attained. 
 
Information on training and initial employment is available for 119 people (50%).  
After leaving school 13 (11%) went onto further education, 27 (23%) went into 
vocational training, 57 (48%) went into employment and 22 (18%) were 
unemployed. 
 
Activity and employment 
 
Of those 237 people in contact with services during the six months prior to death, 
up to date information on employment status during this period was scant in all 
casefiles making detailed interpretation of this data difficult.  Information on 
income was available for 125 of the 237 (52%).  This showed that, of the 125, 
105 (84%) were unemployed during the six months prior to death.  There was no 
information on daily activity or routine. 
 
Fiscal files did contain some occupational details in 123 (41%) of the 300 files 
available.  Fifty-seven (46%) of these people were unemployed and 6 retired.  In 
the case of the other 177 people (59%) however, no information was available on 
occupational status.  Twenty-six people (including 5 whose occupation was not 
recorded in the case notes) were working at the time of their death, representing 
14% of those where data on employment status were available.  Of the 162 
people not working at the time of their death, 29 (17%) were claiming 
unemployment benefit and 13 (8%) were on sickness or incapacity benefit.  
However, in the remaining 74% of unemployed people, no information was 
available.  
Interpretation 
 
Employment and meaningful activity is well recognised as having an impact on 
ability to progress in terms of moving on from a life dominated by drug misuse.  
Despite this there is very little available up to date information in current 
casenotes regarding occupational status or daily activity in this population.  From 
the limited information available, however, there is a suggestion that this 
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population represents a broad range of skills and occupations.  It should also be 
recognised that a small number were retired or suffered chronic illness. 
 
Living arrangements 
 
Of 138 for whom information on living arrangements was available, 74 (54%) 
lived alone and 64 (46%) lived with others.  Twenty nine of those were recorded 
as living with a partner, 32 with parents and three with dependent children.  Data 
were unavailable for the remaining 98 cases. 
 
Supportive relationships 
 
Information was sought from records on the nature of relationships between the 
deceased and their family and friends.  Specifically information was sought on 
whether people had felt close to any particular person and whether there had 
been any difficulties recorded in the relationships with family and friends in the 
six months prior to death. 
 
Data relating to these questions were largely missing with 159 people having no 
mention of the quality of their relationships in any recent records.  Seventy eight 
(33%) did contain such information.  Of these, 69 (88%) suggested a 
close/supportive relationship with their family while nine records (12%) did not. 
 
Of the 300 fiscal files, information was available on relationships for 207 (69%) 
people.  They state that, at the time of death, 98 (33%) were described as being 
‘in a relationship’ while 109 (36%) were ‘unattached’.  In some cases they also 
record contacts with friends and family.  Regarding their family, data were 
available for 214 (71%) people.  Of these 214, 167 (78%) had had contact within 
three days of death, 37 within the last few weeks and six within the last year.  
Regarding friends, data were available for 203 (68%) people of whom 188 (93%) 
had contact within 72hrs, 13 within the last few weeks and one within six months. 
 
Interpretation 
 
The lack of information in this area implies that services do not routinely gather 
or update information on living arrangements or supportive relationships.  Even 
when this is collected, the information is relatively rudimentary and limits the 
degree of interpretation that is possible regarding the social support available for 
an individual and the impact this may have on individual vulnerability.  Where 
data were available, the majority of people who had died of drug related causes, 
who had been in contact with services during the six months prior to that death, 
showed characteristics not dissimilar to the general population – they showed a 
broad range of educational attainment and many progressed to employment or 
training immediately after completing school, though by the time of death the 
majority were unemployed; they lived in a range of environments, with the 
majority in stable accommodation; many were in a positive relationship and were 
not socially isolated, retaining contact with their friends and family.  It must be 
stressed however, that, due to the degree of missing information in casefiles, this 
interpretation cannot be generalised. 
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Case study  
Young female.  Died of acute intoxication with methadone, benzodiazepines 
and amitriptyline.  She was registered as unemployed (but notes state she 
was a sex-worker) and was homeless as her long-term relationship had 
ended.  She had been admitted to hospital following a deliberate overdose but 
discharged herself against medical advice and was found dead that evening. 
 
She had a complex past history including a poor relationship with her parents 
resulting in foster placement from the age of eight years.  She reported 
sexual abuse while in care.  In 1992 it is recorded that she cut herself 
following an argument with a boyfriend.  The notes then record a long history 
of deliberate self-harm.  Her GP treated her for depression from 1992.  All of 
her children had been taken into care. 
 
She was involved in a wide range of drug-related criminal activities from her 
teens.  She was referred for detoxification twice but she always returned to 
drug misuse.  She was prescribed methadone and diazepam briefly but failed 
to attend appointments and her case was closed.  She tested positive for 
Hepatitis C in 1998.  In the six months prior to death, her casenotes describe 
chaotic drug use.  Although she had a history of custodial sentences, she had 
no periods of custody in the six months prior to death. 
 
 
 
Relationship with children 
 
Casefiles show that, of those 237 people in contact with services during the six 
months prior to death, 119 (50%) had children while 55 (23%) did not.  No 
information was available in 63 (27%) casefiles.  The 119 who were identified as 
parents, had 185 children.  Twenty seven children (15%) were under five years of 
age, 110 (59%) were aged 5 to 16 years and 48 (26%) were over 16.  Seventeen 
of these children (9%) were recorded as living with a parent who suffered a drug 
related death.  78 (42%) were living elsewhere and 2 were in care.  No 
information on where these children were living was available in 88 (48%) 
casefiles.  Of 59 females who died, casefiles record that 16 (27%) had children in 
their care at the time of their death. 
 
Information was sought from fiscal files only on children in the care of the 
deceased.  Thirty two people (16 females, 16 males) are recorded as having 54 
children in their care at the time of death with 16 having one child, 11 having 
two, four having 3 and one person caring for 4 children.  There were 227 cases 
where there were no children in the subject’s care at the time of death.  For 41 
people the situation regarding childcare could not be determined. 
 
The CSC and fiscal file datasets were manually compared using unique identifiers, 
to determine any similarities or differences between the populations.  12 of the 
16 people identified from casefiles as having responsibility for children were also 
identified as having childcare responsibility in the fiscal files.  Of the 32 people 
identified in the fiscal files as having responsibility for children, the CSC data 
showed that 11 had childcare responsibilities.  In five cases, the CSC files stated 
that their children were cared for elsewhere while in 16 cases the situation was 
unknown or not recorded in their files. 
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Interpretation 
 
Drug users often have complex lives and we must be cautious interpreting these 
data.  For example, a drug misuser may not have day to day responsibility for 
child care but may see and support their child regularly and be a significant part 
of their life.  It is clear however, that of 119 parents who died as a result of a 
drug-related death, fiscal files suggest that 32 were responsible for caring for 
their children during the six months prior to death.  Fifty four children were being 
cared for by a drug user who died. Three quarters of all affected children of which 
we are aware were of school age. 
 
The comparison of the two datasets implies that the quality of basic information 
on childcare arrangements is generally poor with no updated notes on the 
situation available in the six months prior to the death.  Casefiles had a record of 
child care responsibilities in less than 50% of those identified in fiscal files. This 
means that the information informing decision–making around family support and 
child-protection in day to day practice may be inaccurate.  In the context of 
recent reports (eg. “Hidden Harm”) and published advice on improving practice 
(e.g. “Getting our Priorities Right”) there are still people in contact with services 
about whom we know little regarding their parental responsibilities.  If available, 
this information would help identify the risks to the child and allow staff to better 
identify the needs of that family.  It must also be recognised that, even if a child 
is not directly cared for by a parent who dies, they will inevitably be impacted 
upon by that death. If they are not known, appropriate support may not be made 
available for them. 
 
Environment 
 
This section contains information regarding where the person lived – their 
accommodation and broader environment. 
 
Environment – living accommodation 
 
Data on accommodation at the time of death have been presented in a previous 
section of this report.  Of those 237 people in contact with services during the six 
months prior to death, general information was available in 168 casefiles (70%).  
Of the 237, only 117 (49%) were recorded as living in their own house or flat.  
Thirty one (13%) were in unstable or temporary accommodation.  A quarter of 
people had stayed in their most recent accommodation for less than six months, 
half between 6 months and five years and a quarter had lived for over five years 
at the same address.  Only eight people were recorded as having been roofless 
during the six months prior to death.  Information on Prison is contained in the 
next chapter. 
 
Life events 
 
Information was sought from service casefiles on history of traumatic or 
significant events in the six months prior to death.  Sixty-seven (26%) of the 237 
cases identified via clinical records had one or more significant events recorded in 
their notes within the six months prior to death (Table 4.1).  Eleven recorded two 
significant events and four cases recorded three events each. 
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Table 4.1: Number and type of significant events recorded in case notes 
of drug related death cases in the 6 months prior to death (n=67) 
 
Significant Event Number 
Separation due to marital difficulties or broken off a steady 
relationship 
25 
Bereavement 17 
Child custody issues 12 
Physical illness presented for the first time 10 
Serious injury, illness or assault to close relative 9 
Serious problem with a close friend, relative or neighbour 6 
Psychiatric illness presented for the first time 5 
 
 
Interpretation 
 
Significant life events do appear in the records of a significant minority of people 
who suffer a drug-related death.  As drug users experience many such events and 
present their difficulties to the professionals working with them regularly, it is 
likely that other relevant events are not recorded.  Clinically it is well recognised 
that substance misusers do experience high levels of trauma and negative life 
events but it is impossible to determine the significance of the events recorded 
for these cases.  It is however essential that staff take steps to ensure that they 
are fully aware of the stresses being experienced by an already vulnerable group, 
as this may allow early intervention and support. 
 
Conclusions 
 
This chapter explores important social variables that may have a significant 
impact on the individual’s ability to cope with negative life events.  This 
information should have been available for all individuals in contact with services 
and it is of concern that in many cases it is not. It is likely that more detailed 
information was recorded at the time of initial assessment by a service.  The 
limited information that was available with regard to the previous six-month 
period, however, highlights the need for staff to regularly review individuals’ 
social circumstances.  This is of particular importance regarding child care 
responsibilities.  With the limited clinical information available this study has 
identified no social risk factor, knowledge of which will prevent drug-related 
deaths. 
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Key Points 
 
 
• Information in casefiles, as it is currently collected across Scotland is sparse, 
inconsistent and difficult to cross-reference.  A standardised, well-validated 
method of collecting agreed data on all drug deaths would ensure that any 
relevant social risk factors may be identified. 
  
• The lack of up to date relevant information in many of the casefiles, which 
would be required to organise an integrated care plan is a concern.  The 
availability of rich, up to date information must form part of good practice in 
the management of drug misusers. 
 
• Risk assessment is not routinely recorded.  Good quality standardised 
information will allow identification and prioritisation of potential risk factors in 
this vulnerable population which could reduce future morbidity and mortality. 
 
• Staff in all settings should be trained to comprehensively assess drug 
misusers and to ensure that regular updates of essential information (e.g. 
regarding childcare responsibilities, life events etc.) are recorded to allow 
improved awareness of a person’s needs and greater evaluation of the 
significance of personal and social factors. 
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What is in this chapter?  The information below sets out the nature and 
frequency of contact with services and identifies the overall patterns of these.  
The information described in this section should be regarded, and read, as 
population trends rather than the contact patterns of individual cases. 
 
Where did the information come from?  Data were drawn from different 
sources to build a comprehensive picture: 
1. Records of care/interventions were identified and accessed for 305 (96%) 
people who ever had contact with services.  No records were available for 12 
cases.  Of the 305 for whom records were available, 237 (78%) had had 
contact with one or more services during the 6 months prior to their death 
and information was extracted from the records of all services known to be 
involved in their care.  For the remaining 68 people, their casefiles showed no 
record of any service contact in the 6 months prior to their death. 
2. Information was collected from hospital returns data (ISD databases 
SMR00/01/04) identifying 227 (72%) cases who received hospital care in the 
year prior to their death. 
3. Two hundred and seventy-four of the 317 drug deaths (86%) were known 
to the Scottish Criminal Records Office. 
4. Seventy of the drug-related deaths had been in a Scottish Prison in the six 
months prior to death and SPS files were accessed to add depth to the CSC 
dataset. 34 people had been offered formal Transitional Care and information 
was made available regarding whether this was accessed and outcome. 
 
Chapter 5:  Service contacts in the 6 months prior to  
 death 
 
Introduction 
 
“Integrated Care for Drug Users, Principles and Practice” (EIU 2002) 
acknowledges that people with drug problems often have multiple needs and do 
not access services in a uniform manner.  They will move in and out of contact as 
needs arise, accessing a range of different agencies in an ad-hoc way.  This poses 
difficulties for services in terms of ensuring that they give an appropriate 
response to meet the user’s needs and collaborate effectively with partner 
agencies to maximise outcomes.  This section considers information from diverse 
sources to help understand this process and identify potential areas where a 
timely intervention may impact on outcome. 
 
Mapping contact with health and social care services  
 
It is recognised that being engaged in a process of care and treatment has a 
positive impact on outcomes, including drug-related deaths.  In order to co-
ordinate and integrate the care that is provided to individuals it is important to 
recognise the extent to which people access more than one service and the 
various interventions which they may be accessing from these services. 
 
Of those 305 people who died of drug-related causes in Scotland in 2003 and for 
whom records were available, 68 people had no recorded service contacts at all 
during the six months prior to death.  Data from the health, social work and 
independent sector casefiles of the 237 people who had been in contact with 
services during the six months prior to death were examined to determine the 
extent of service involvement, including their degree of engagement, the number 
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of services involved (including whether these were generic or specialist) and the 
purpose of attending – including the types of interventions received. 
 
Degree of engagement - time intervals between last service contact and 
occasion of drug-related death 
 
The table below (Table 5.1) describes the number of people who were in contact 
with any service during the six months prior to death and the time interval 
between last recorded contact with services and death.  Of the 237 cases that 
had contact with services in the 6 months prior to their death, 136 (57%) were 
still in contact with at least one service within one month of their death. 
 
Table 5.1: Number of cases in contact with any service at any month in 6 
months prior to death (n=237) 
 
Number of 
cases 
Month 1  
(Prior to death) 
Month 
2 
Month 
3 
Month 
4 
Month 
5 
Month 
6 
In contact with 
services 
136 186 213 226 233 237 
Last contact 
with services 
136 50 27 13 7 4 
 
Number of agencies involved 
 
Table 5.2 shows the number of agencies accessed by individuals in each of the six 
months prior to death. This table does not describe multiple contacts with any 
single agency.  In their last month prior to death 136 people had 175 agency 
contacts on at least one occasion.  During this period, over half of those who 
experienced a drug-related death in 2003 had documented contact with only one 
service.  Some accessed many services though none accessed more than 8 
services in any one month. 
 
Table 5.2: Number of agencies accessed by each person 
 
Number of 
individual 
agencies 
accessed 
by each 
person 
Month 1 
Prior to 
death 
(n=136) 
Month 2 
Prior to 
death 
(n=186) 
Month 3 
Prior to 
death 
(n=213) 
Month 4 
Prior to 
death 
(n=226) 
Month 5 
Prior to 
death 
(n=233) 
Month 6 
Prior to 
death 
(n=237) 
1 104 116 119 106 107 107 
2 50 60 58 63 59 54 
3 16 22 23 24 25 30 
4 4 9 5 4 5 7 
5 1 4 3 6 4 4 
6 0 0 0 4 1 1 
7 0 3 0 1 0 1 
8 0 1 1 1 0 0 
Total 175 215 209 209 201 204 
 
Services used 
 
Table 5.3 shows the main services accessed in each NHS Board area at any point 
during the six months prior to death.  The list of services is not exhaustive – i.e. 
people also had contact with additional agencies during this period, but in very 
small numbers.  The table illustrates that the pattern of contact is not uniform 
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across Scotland, with different services in each area apparently having more 
contact with this group.  This may reflect the local pattern of services available. 
 
Some patterns do appear across Scotland as a whole.  Significant contact was 
with general practitioners (GPs), with 183 (77%) of all those in contact with any 
service accessing GPs during this period.  General Practitioners may have some 
formal links with specialist services through “shared care” arrangements.  In most 
areas, the majority of contact was not with specialist drug services but with 
generic providers.  Over all only 40 (17%) were known to specialist services, 
while in most areas there were significant contacts with psychiatric services (41 
people, 17%), acute services – including Accident & Emergency (59 people, 22%) 
and NHS outpatients of various types (37 people, 15%). 
 
In total, 71 (30%) were known to Social Work over all, though one area (NHS 
Glasgow) is responsible for over half of all Social Work contacts identified.  In 
most other areas there was limited Social Work contact recorded.  The Glasgow 
data regarding Social Work teams allows a break down of specialist/generic 
involvement. This shows that, of the 42 people in contact with Social Work, 11 
were being seen by a “generic” team, four by the “homelessness” team and 10 by 
Criminal Justice. Only 17 (40%) were being seen by specialist drug & alcohol 
Social Work staff.  Organisation of Social Work services will vary from area to 
area. 
 
Table 5.3: Number of drug-related deaths accessing specific services 
during 6 months prior to death  by NHS Board area (n=237) 
 
 GP & 
Primary 
Care 
team 
Social 
Work 
Psychiatry Acute 
services 
(& 
A&E) 
NHS 
Out-
patients 
Specialist 
drug & 
alcohol 
services 
Voluntary 
sector 
Residential 
Argyll & 
Clyde 
17 3 0 7 2 4 1 0 
Ayrshire & 
Arran 
10 3 7 2 1 5 3 1 
Borders 1 0 0 0 0 0 0 0 
Dumfries & 
Galloway 
3 0 2 2 1 0 0 1 
Fife 7 3 9 4 2 1 0 0 
Forth 
Valley 
9 1 1 6 1 4 0 0 
Grampian 23 9 4 2 9 0 0 1 
Greater 
Glasgow 
57 42 0 17 11 6 4 4 
Highland 3 0 3 0 0 1 1 0 
Lanarkshire 14 8 7 7 2 6 0 0 
Lothian 25 10 4 8 5 8 0 2 
Tayside 14 0 3 4 3 3 0 0 
Western 
Isles 
0 0 0 0 0 0 0 0 
Scotland  183 71 41 59 37 40 9 9 
 
Purpose of contacts  
 
Table 5.4 describes the main reasons for contact with services in each of the six 
months prior to death.  It identifies the number of times a particular type of 
contact was made by different people in any one month.  It does not capture 
multiple interventions delivered to the same person in the same month, e.g. one 
person attending for a “medical consultation” three times in the month before 
death would only be noted as one event. 
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Table 5.4: Reasons for contact with services in the 6 months prior to 
death. 
 
Reason for contact Contacts 
in 
Month 1 
Contacts 
in  
Month 2 
Contacts 
in  
Month 3 
Contacts 
in  
Month 4 
Contacts 
in 
Month 5 
Contacts 
in 
Month 6 
Total 
contacts 
over 6 
months 
Medical 
consultation 
 
73 101 98 105 98 103 578 
Medical emergency 
(Including A&E) 
13 12 6 6 12 8 57 
Other medical care 
 
5 8 5 8 6 7 39 
Substance misuse 
assessment 
0 6 2 5 3 2 18 
Detoxification 
 
0 6 5 2 4 1 18 
Specialist 
substitution 
prescribing 
programme 
8 9 11 11 8 10 57 
Out-patient 
psychiatry 
 
8 13 15 12 10 12 70 
Emergency 
psychiatric care 
5 2 4 3 2 4 20 
Psychiatric 
hospitalisation 
0 5 4 4 2 1 16 
Case management 
(Social Work) 
29 29 27 29 28 24 166 
Psychosocial 
interventions 
including Counselling 
8 3 6 7 11 8 43 
Other 
 
32 23 28 22 19 27 151 
Total 
 
181 217 211 214 203 207 1233 
 
Forty-seven per cent (47%) of all contacts recorded in the six months prior to 
their death were “medical consultations”, the majority with GPs in primary care. 
Only 5% of contacts were described as “specialist substitution prescribing 
programmes”. However, 66 people (24% of those in contact with services) were 
prescribed methadone during the 6 months prior to death, with 40 still prescribed 
at the time of death.  80% of all information on methadone prescribing was 
extracted from General Practitioners’ notes, showing that, for the drug related 
death population, the majority of methadone prescribing was in the primary care 
setting with a significant proportion of these “medical consultations” relating to 
replacement prescribing.  “Shared care” schemes operating throughout Scotland 
are modelled on the premise that stabilised drug users are generally seen in 
general practice and those whose drug use is more chaotic or problematic are 
cared for by specialist drug services.  The data presented here may imply that 
this type of “shared care” model is not operating in practice in many areas of 
Scotland as it would be expected that the more chaotic users (who would be 
attending the “specialist services” in such a model) would be more at risk of drug-
related death. 
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Case study  
Young adult male.  Post mortem states he died of cocaine intoxication.  
Diagnosed as suffering from paranoid schizophrenia for 15 years resulting in 
three admissions to psychiatric hospital.  He was also known to be opiate 
dependent and a user of cocaine and crack cocaine.  He was an IV drug user.  
He was unemployed having never worked, living on benefits in his own flat. 
 
The 6 months prior to his death were dominated by residential treatments.  
He was admitted to a residential rehabilitation facility for 4 months before 
discharge and immediate admission to another.  On the day of his death, he 
self-discharged, returned home and injected cocaine in the presence of an 
acquaintance.  He was found dead the next morning. 
 
He was under the Care Programme Approach and was present at two care 
management meetings 4 and 6 months prior to death. These were attended 
by forensic psychiatry and the homeless social work team all of whom were 
involved in his ongoing management.  The police report suggests he was in 
receipt of a depot anti-psychotic drug – but toxicology does not show this to 
have been present at death. 
In Scotland, General Practitioners have taken on a more prominent leading role in 
the delivery of methadone replacement prescribing – reflecting a lack of capacity 
and waiting lists in specialist services.  This may explain the apparently skewed 
balance of prescribers in this investigation. 
 
“Case management” – delivered by Social Work - accounted for 12% of contacts 
while counselling – supposedly a key element of care for drug misusers in 
treatment - accounted for only 3% of all contacts.  Appendix 4 contains a list of 
all contacts defined as “other” in Table A4.1. 
 
It is notable that the majority of the contacts (other than with a doctor or social 
worker) appear to be in emergency situations (A&E, emergency psychiatric care). 
 
Interpretation  
 
This is not an unknown population.  Only 68 (21%) of those who died of drug-
related causes in Scotland in 2003 and for whom records were available had had 
no recorded contact with any agency in the six months prior to death.  Of the 237 
who had service contact, many were accessing multiple services and more than 
50% were still in contact with at least one agency at the time of death.  The 
agencies involved include specialist services, but contact was dominated by 
attendances at generic services – mainly general practitioners but also psychiatric 
services, acute hospital services (including Accident & Emergency), NHS out-
patients and social work.  Contacts were often for the purpose of delivering 
medical interventions or a response to an emergency situation.  There is a 
notable lack of recorded contact for delivery of counselling services or other 
psychosocial interventions.  This pattern of contact implies that, if services are to 
have an impact on drug deaths, this will have to reflect activity in the more 
generic health and social care settings – areas where concern regarding drug use 
may not be the priority of the professional concerned during that contact. 
 
More detailed analysis of the specific treatment received from health services is 
contained in the next section. 
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Contact with Health Services 
This section describes in more detail the care of individuals who had received 
medical treatment for drug misuse and, when possible, compares the clinical care 
received by those who were in treatment with national clinical guidelines and 
considers whether there was anything that “services” could have done, or could 
do in the future, to prevent death.  Data were extracted from national ISD 
databases relating to episodes of health care and, when these data are used, the 
definitions reflect those under which these data were recorded by the staff 
responsible for their care. 
 
Hospital admissions 
 
Initial analysis of data obtained from selected ISD databases (SMR 00/01/04) 
indicates that in the year prior to death there were 1435 recorded episodes of 
hospital care for this population (n=317).  This does not include attendances at 
Accident & Emergency Departments not resulting in admission, as ISD does not 
collect these data.  Of these 1435 episodes, 734 resulted in hospital admissions 
(51%), of which 198 (27%) were discharged the same day, 220 (30%) after one 
day and a further 95 (13%) after two days. Five hundred and thirteen (70%) of 
all hospital admissions for this population were for two days or less. 
 
SMR returns recorded general reasons for admission for only 340 of these 734 
episodes: 296 to a general hospital and 44 psychiatric admissions. Reasons for 
admission were not recorded for the remaining 394 admissions.  The majority of 
general hospital admissions for which this information was available were classed 
by ISD as having been for “observation, treatment or investigation” although 49 
(17%) were for “self-inflicted injury” and a further 26 (9%) for “accidental or 
other injury”. 
 
Psychiatric treatment  
 
In the six months prior to death 86 (36%) people were prescribed anti-
depressant medication.  Of these, 75 (87%) were prescribed these medications 
by their general practitioner.  Twenty people were prescribed anti-psychotic drugs 
with two receiving Clozapine (a drug requiring close review by mental health 
services) and one received a depot antipsychotic which would require regular 
contact with professionals to administer.  Table 5.5 sets out the drugs prescribed. 
 
Table 5.5: Medical treatments for psychiatric disorders 
 
Drug prescribed 
Type of drug Drug name Trade name 
Number of 
people 
Venlafaxine Efexor 18 
Citalopram Cipramil 18 
Fluoxetine Prozac 15 
Trazodone Molipaxin 10 
Paroxetine Seroxat 9 
Amitriptyline Tryptizol 9 
Dothiepin Prothiaden 6 
Antidepressants 
Doxepin Sinequan 1 
Olanzapine Zyprexa 9 
Haloperidol Haldol 3 
Chlorpromazine Largactil 3 
Clozapine Clorazil 2 
Zuclopenthixol Clopixol 1 
Flupenthixol Depixol 1 
Antipsychotics 
Trifluoperazine Stelazine 1 
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In the casefiles of the 273 people who had been in contact with services during 
the six months prior to death, 83 had at least one episode of psychiatric care 
recorded.  Casefiles show that five people had records of at least five different 
treatment episodes in the last six months. 
 
SMR04 data shows that 44 of the psychiatric contacts made by these 83 people 
required hospital admission.  Records were available for 28 of the psychiatric 
contacts.  Table 5.6 sets out the nature of these 28 contacts.  The definitions 
reflect those recorded by the clinicians delivering the care. 
 
Table 5.6: Psychiatric service contacts 
 
Nature of contacts Number of contacts 
Psychiatric assessment 4 
(Thoughts of) Self harm 4 
Anxiety 3 
Paranoid schizophrenia 3 
Personality disorder 3 
Depression 2 
Suicidal ideation 2 
Mental health review 2 
Substance misuse 1 
Schizophrenia 1 
Emergency psychiatric care 1 
Alcohol detoxification 1 
Paranoid delusions 1 
 
In SMR04, aftercare details are recorded for the 44 episodes of psychiatric care 
that required hospital admission, relating to the care of 29 people. Of these 
episodes, 22 (50%) cited ‘GP’ as the planned aftercare arrangements, nine (20%) 
cited outpatient clinics, four (9%) community care teams and two psychiatric day 
hospitals.  Two were transferred to psychiatric wards for ongoing care.  No details 
were recorded for the remaining eight episodes.  No referrals to Social Work or 
any voluntary agency were recorded in any casefiles following these episodes of 
care. 
 
Previous non-fatal overdose 
 
One hundred and thirty eight (50%) of the people who were in contact with 
services in the six months prior to death had details of previous overdoses 
recorded in their notes.  The tables below (Tables 5.7 and 5.8) set out the 
assessed nature (i.e. accidental or deliberate) and frequency of overdoses and 
the treatment received for each overdose event.  In some cases, other than to 
mention that an overdose had occurred, no specific details were available. 
 
The tables show that four people had been treated for at least four non-fatal 
overdoses in the six months prior to death.  The number seen at A&E exceeds the 
number seen by ambulances indicating that some overdoses arrived at A&E 
departments via means other than ambulance conveyance.  This suggests that 
ambulance records of overdose attendances underestimate the total number of 
overdoses attended to by professional staff.  Of the total number of people 
admitted into hospital for overdose, 44 (57%) were psychiatrically assessed, and 
in most cases (95%), psychiatric follow-up was arranged.  Of these, however, 
less than half (43%) presented for follow-up and no further action was recorded 
for those who did not attend. 
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Table 5.7: Number of people experiencing non-fatal overdoses by type 
(n=118) 
 
Number of 
overdoses 
At least 
1 
1 2 3 or 
more 
Type 
1 
Type 
2 
N/K 
Ever 138 64 29 37 43 51 44 
Last 6 
months 
31 21 8 2 9 13 9 
Type 1 – accidental 
Type 2 - deliberate 
 
Table 5.8: Treatment received by episode of non-fatal overdose 
 
OD 
before 
death 
Ambulance 
called 
Treated 
at scene 
Seen at 
A&E 
Admitted 
to 
hospital 
Psychiatric 
diagnosis 
Follow-
up 
arranged 
Attended? 
 Yes No Yes No Yes No Yes No Yes No Yes No Yes No 
Last 27 2 7 8 59 1 50 8 23 14 21 21 7 9 
2nd Last 14 1 5 1 29 0 16 4 13 8 12 10 4 3 
3rd Last 6 0 1 1 12 0 9 1 6 1 6 2 5 0 
4th Last 1 1 1 0 4 0 2 1 2 1 3 0 2 1 
Total 48 4 14 10 104 1 77 14 44 24 42 33 18 13 
 
Specialist treatment for drug or alcohol problem in the last 6 
months 
 
Data obtained from casefiles indicated that in the six months prior to death, only 
38 (12%) of the 317 people had at least one contact with a specialist drug misuse 
service.  Details relating to the majority of these contacts were not routinely 
noted in clinical records.  Table 5.9 below summarises the interventions for the 
47 recorded contacts by these 38 people. 
 
Table 5.9: Type and frequency of specialist drug treatment contact 
(n=38) 
  
Intervention Number of contacts 
Drug dependence 10 
Assessment 8 
Drug detoxification 8 
Did not attend 4 
Referral 4 
Alcohol detoxification 3 
Residential rehabilitation 3 
Initial contact 2 
Treatment for hallucinations 1 
Methadone reduction programme 1 
Alcoholics Anonymous 1 
Day hospital attendance 1  
Crisis intervention 1 
Total  47 
 
Medical treatment for a drug problem 
 
There is a relationship between dose and outcome in methadone prescribing with 
higher doses associated with better clinical and harm reduction outcomes.  Good 
practice is for methadone prescribing to be delivered alongside various 
psychosocial or counselling interventions, an approach which has also been 
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associated with better outcomes.  Prescribing guidance recommends an optimal 
dose range of 60-120 mg of methadone per day.  Risks (including those of 
overdose) increase when methadone is reduced or stopped.  National Clinical 
Guidance on prescribing for drug misusers makes it clear that methadone 
prescribing should only follow adequate assessment of extent of drug problems 
and dependence.  Initial methadone dispensing should involve supervision of 
consumption with progress to “take home” dependent on successful stabilisation 
(Drug Misuse & Dependence. Guidelines on Clinical Management HMSO 1999). 
 
Seventy-eight people were receiving medical treatment for a drug problem in the 
six months prior to death, of which 66 were prescribed methadone by their 
general practitioner or specialist service doctor.  No records of other specific 
medical treatments for drug misuse were recorded – though in three cases it was 
noted that one had received “detoxification”; one “assessment” and one 
“tolerance testing”. 
 
Identification of dependence 
 
All case records available for those who had ever had access to any services 
(n=305) were searched for documented, objective evidence of the person having 
a recognised dependence syndrome.  Only eight case records (2.6%) had this 
information recorded. 
 
Methadone dose 
 
Sixty six people were prescribed methadone during the six months prior to death.  
Only 40 were prescribed methadone by their time of death.  For one person, 
information on dose or duration of prescription was unavailable in any case 
record. 
 
For the remaining 39, dose range was from 4 to 100 mg (mean 53.9; SD 24.1).  
Sixteen people (34%) were prescribed 60 mg or more while 24 (66%) were 
prescribed less than 60 mg.  When dose at death is compared with their previous 
recorded dose it can be seen that 21 people (54%) were having their methadone 
dose increased and 8 (20%) were being reduced.  In 11 (28%) cases there is 
inadequate information in casefiles to determine prescribing plans or trends. 
 
People had been on methadone treatment for varying periods.  No information 
was available on duration of treatment in 9 cases.  Duration of prescription 
ranged from 2 days to over 7 years (mean 19.6 months; SD 26.93).  Four had 
been in treatment for up to 1 month, 10 between one and 6 months and four 
between 6 months and one year. A further four had been treated for up to 2 
years, three up to 5 years and four more than 5 years. 
 
Prescribing information was available in casefiles for 14 of the 26 no longer 
receiving prescribed methadone.  No records were available for the remaining 12 
people.  When available, records show that prescriptions ended between two days 
and eight months before death occurred.  Table A4.2 in Appendix 4 displays these 
data in more detail. 
 
Dispensing arrangements 
 
Of the 40 who were receiving prescribed methadone at the time of their death 27 
(68%) collected their methadone daily, either six or seven days per week.  One 
person collected their prescription three days per week, five collected once a 
week and one person did so every two weeks.  Arrangements for the remaining 
six cases were not recorded in casefiles. 
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Case study  
A 35 year old man who was started on a methadone prescription for 50 mg 
daily on Tuesday.  He died on Friday of a heroin, methadone and 
benzodiazepine overdose. 
 
No record of assessment, prescribing decisions, dispensing arrangements nor 
access to counselling or support was available in any casefile. 
 
Information on method of consumption was available for 32 of the 40 people 
receiving prescribed methadone at their time of death.  This is displayed in table 
5.10.  Six collected their methadone from a treatment centre of whom five 
consumed their methadone under supervision.  Of the 26 people who collected 
their methadone from a community pharmacy, 21 (81%) consumed their 
methadone under supervision on the pharmacy premises and five (19%) 
consumed at home. 
 
Table 5.10: Method of collection and consumption of methadone 
 
Method of 
collection/consumption 
Number of cases 
(Frequency) 
Mean dose 
(mgs) 
Range 
(mgs) 
Collection from treatment centre – 
Supervised consumption 
5 43 10-80 
Collection from treatment centre – 
Consumption at home 
1 60 60 
Collection from pharmacy – 
Supervised consumption on 
premises 
21 58 20-100 
Collection from pharmacy – 
Consumption at home. 
5 44 4-80 
 
Of the five people who collected from the pharmacy and consumed at home, two 
were homeless and another two were on anti-depressant medications – implying 
they had complex problems.  Notes recorded no evidence of injecting for any of 
these people in the last six months but no other indicators of stability were noted.  
All were unemployed and none had attended any specialist drug treatment 
services. 
 
Non-specialist Detoxification 
 
Clinical case notes recorded 26 people attempting to abstain or detoxify from 
drugs in the six months prior to death.  Nine (34%) were recorded simply as self-
detoxification.  A further 10 (38%) were aided by a prescription from their GP, 
and seven cases (27%) sought abstinence by other means.  Outcome data were 
recorded for 23 of these cases. Seven (27%) successfully completed 
detoxification and appeared to remain drug free until death.  11 (42%) completed 
detoxification but relapsed, and the remaining five (19%) did not complete their 
detoxification.  Few details are recorded. 
 
Did not Attend (DNA) rates 
 
Very little was recorded in service case notes and/or other information systems 
regarding ‘Did Not Attend’ rates.  This cannot therefore be commented on. 
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Waiting times 
 
Of the 237 cases in contact with services in the six months prior to death, 19 
(8%) were identified to be on any waiting list.  Only two of these were on a 
waiting list for a drug treatment or intervention service. 
 
Interpretation 
 
Of the 317 people who experienced a drug-related death in Scotland in 2003, 
only 66 were prescribed methadone during the six months prior to death.  Of 
these, 26 (39%) were no longer prescribed methadone by the time of death.  
There was little information regarding the assessment carried out prior to 
initiation of a prescription with only 8 people having any records showing 
assessment of dependence prior to prescribing.  Records for those prescribed 
were also limited with inadequate information available in 28% of casefiles to 
determine whether prescriptions were increasing or decreasing.  Of those 
prescribed methadone at the time of death, 66% were on sub-optimal doses of 
less than 60 mg though 54% were increasing their doses.  Records of dispensing 
arrangements show that those 5 people who were taking their methadone home 
may not have been stable with two described as homeless and two on 
antidepressants.  Only 11% of people on methadone received any recorded 
counselling interventions during that period.  Only one person prescribed 
methadone at the time of death was also in receipt of counselling. 
 
The quality of recording in casefiles was often poor making judgements of the 
quality of care received impossible in many cases.  In those where information 
was available, it is clear that there were inconsistencies in the delivery of 
methadone prescribing for this group, some of which fell outside the standards 
set in the available clinical guidance. 
 
Contact with Criminal Justice System 
Limited data were made available from the Scottish Criminal Records Office 
(SCRO).  Two-hundred and seventy four (86%) of those suffering a drug-related 
death in Scotland in 2003 were ever known to SCRO.  Almost all (83%) of those 
known to SCRO were aged 20-40yrs. Detailed arrest data were not accessed 
during the investigation study period. 
 
Contact with community- based specialist criminal justice schemes  
 
Information on contact with community-based specialist criminal justice schemes 
showed very little contact for this population (Table 5.11).  The available data 
may be an underestimate as some contacts may be unrecorded.  It should also be 
noted that many of these initiatives were in their infancy in 2003 or were 
unavailable in some areas of the country. 
 
Table 5.11: Contact with community based specialist criminal justice 
schemes 
 
Type of 
service 
YES 
Ever 
YES 
<6months 
NO  UNKNOWN 
ARS 0 0 31 (10%) 274 (90%) 
DFP 6 (2%) 0 17 (6%) 282 (92%) 
CBATCS 23 (8%) 8 (2%) 12 (4%) 270 (88%) 
DTTO - 7 (2%) 41 (13%) 257 (85%) 
Drug Court - 5 (2%) 34 (11%) 266 (87%) 
EPO - 7 (2%) 38 (13%) 270 (85%) 
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ARS – Arrest Referral Scheme 
DFP – Diversion from Prosecution Scheme 
CBATCS – Community-based Alternative to Custody Scheme 
DTTO- Drug Treatment and Testing Order 
EPO – Enhanced Probation Order 
 
Outstanding charges at time of death were recorded in 21 cases (8.9%).  
 
Contact with Scottish Prison Service  
 
Of the 317 cases, 149 (47%) had previously had a prison sentence.  Of these, 70 
(47%) died within 6 months of release, including thirty-six deaths (24%) which 
occurred within one month of release, 10 (28%) of which were within three days 
of release.  No drug-related death occurred within any Scottish prison in 2003. 
 
These figures represent a reduction in the number of drug-related deaths when 
compared to the previous year (n=383). In 2002 176 (46%) of all drug-related 
deaths had previously had a prison sentence. Fifty four deaths (31%) had 
occurred within one month of release of which 18 (33%) were within three days. 
 
Deaths following Friday release 
 
Table 5.12 sets out the number of deaths that occurred after release from prison.  
Six of the ten people who died within 3 days of leaving prison were released on a 
Friday.  Two of these were from Barlinnie and one each from Edinburgh, 
Greenock, Inverness and Kilmarnock. 
 
It may be that Friday releases are at increased risk of drug-related death. 
However, it should be noted that, of all prisoners released by the Scottish Prison 
Service in 2003 (n=22,915), 32% were released on a Friday as all releases due 
on Saturday, Sunday or Holiday Monday occur on the preceding Friday. 
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Table 5.12: Number of people who died following release from prison 
 
Number of deaths Prison 
Ever been 
in prison 
 Within 6 
months 
 Within 1 
month 
 Within 3 
days 
 
Aberdeen 11 4 3 0 
Barlinnie 49 24 11 2 
Castle Huntly 1 0 0 0 
Corntonvale 13 5 3 1 
Dumfries 3 0 0 0 
Edinburgh 16 5 1 1 
Glenochil 1 0 0 0 
Greenock 10 8 5 2 
Inverness 5 2 1 1 
Kilmarnock 7 5 3 1 
Low Moss 20 12 5 1 
Noranside 0 0 0 0 
Perth 5 2 2 1 
Peterhead 0 0 0 0 
Polmont 7 2 2 0 
Shotts 1 1 0 0 
Total 149 
 
70 
 
36 
 
10 
 
 
Deaths within six months of release 
 
Of those who died within six months of release (n=70) 50 were dependent/long 
term users, one was a recreational user and 19 could not be determined.  
 
Thirty-four (49%) had been convicted and one imprisoned for non-payment of 
fines.  15 (21%) were on remand.  Sentence information was unavailable in the 
CSC file for 20 (29%) of these cases as they had not self-disclosed an addiction 
issue while in prison or this information had not been reported in the records 
identified.  Of the six females who had been imprisoned, one had been convicted 
and the other five held on remand. 
 
Deaths within three days of release from prison 
 
Table 5.13 details factors relating to those who died within three days of release. 
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Table 5.13: Deaths within three days of release from prison 
 
 Age 
(yrs) 
Release 
prison 
Home area Time 
served 
(weeks) 
Release 
– death 
(days) 
Prison 
prescribed 
Prescribed 
on release 
Toxicology
* 
Case 1 41 Kilmarnock Lanarkshire 60 3 Diazepam 
Dihydrocodeine 
No  Heroin 
Diazepam 
Case 2 23 Perth Forth Valley 3 1 No No Heroin 
Case 3 24 Edinburgh Lothian 5 3 No No Heroin 
Alcohol 
Case 4 26 Low Moss Glasgow 10 1 No No Heroin 
Diazepam 
Case 5 26 Barlinnie Lanarkshire 2 3 No No Heroin 
Diazepam 
Case 6 38 Inverness Grampian 4 3 No No Heroin 
Case 7 28 Cornton Vale Glasgow 3 2 No Yes Methadone 
Diazepam 
Case 8 30 Greenock Argyll & 
Clyde 
26 Same day No No Heroin 
Alcohol 
Case 9 31 Barlinnie Glasgow 6 3 Diazepam No Methadone 
Diazepam 
Case 10 37 Greenock Argyll & 
Clyde 
56 2 No No Heroin 
Diazepam 
*Toxicology: Only positive results for Heroin, Diazepam, Methadone and Alcohol are displayed here. 
Other drugs may have been present but not displayed in this table. 
 
Prison record by age group 
 
The Bar chart (Figure 5.14) below illustrates the relationship between age and 
prison record.  It can be seen that around half of those aged between 20 and 40 
years had been in prison at some point in their lives compared to the over-40 age 
group where only one person had ever been in prison. 
 
Figure 5.14: Relationship between age and prison record 
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Transitional care arrangements 
 
In June 2000 the Scottish Prison Service launched a revised drug strategy which 
included plans aimed at effectively managing the transition between prison and 
the community.  “Transitional Care” was introduced by SPS in 2001 to support 
prisoners who were serving less than four years or were on remand and who had 
an identified substance misuse problem.  Prisoners serving more than four years 
do not have access to “Transitional Care” as they are catered for by the SPS 
Sentence Management System and statutory post-release arrangements.  Some 
establishments offer Transitional Care to all drug misusers who are brought to 
their attention.  In others, demand has led to waiting lists.  Self-referral is also 
available in every Scottish prison, even for those not accessing casework 
services. 
 
Scottish Prison Service records show that Transitional Care was offered to 34 
(49%) of the 70 inmates who died of a drug-related death in 2003.  Access to 
Transitional care was unavailable for 14 people (20%).  Eight were on a waiting 
list (HMP Barlinnie only) and one was in HMP Shotts where the scheme is 
unavailable.  Five people in HMP Kilmarnock could only access Transitional Care 
by self referral.  None did.  Ten were not known to Cranstoun (4 in Barlinnie, 4 in 
Low Moss, 1 in Edinburgh, 1 in Inverness).  Notes were not available in 3 cases (2 
in Barlinnie, 1 in Cornton Vale). 
 
Of the 34 offered Transitional Care in Scottish Prisons, 23 (68%) accepted while 
11 did not.  Distribution by establishment is shown in the table below (Table 
5.15).  In the case of those who were not offered formal Transitional Care, or 
were ineligible for it, it cannot be determined from existing data what attempts 
were made to ensure the continuity of care and treatment between community 
and prison, nor can it be determined whether the time in prison was used 
constructively to initiate treatment by referral to outside agencies. 
 
Table 5.15: Offer of Transitional care (n=70) 
 
 Care Offered Accepted 
 Yes No Yes No 
Aberdeen (4 deaths) 1 (25%) 3 0 1 
Barlinnie (24 deaths) 8 (33%) 2 7 (87%) 1 
Cornton Vale (5 deaths) 3 (60%)  1 1 (33%) 2 
Edinburgh (5 deaths) 3 (60%) 1 1 (33%) 2 
Greenock (8 deaths) 6 (75%) 2 4 (67%) 2 
Inverness (1 death) 1 (100%) 0 0 1 
Kilmarnock (5 deaths) 0 5 - - 
Low Moss (12 deaths) 8 (67%) 0 7 (87%) 0 
Perth (2 deaths) 2 (100%) 0 2 (100%) 0 
Polmont (2 deaths) 2 (100%) 0 1 (50%) 1 
Shotts (1 death) Transitional Care not available 
Scotland (70 deaths) 34  (49%) offered  23 (68%) accepted 
 
Interpretation 
 
Transitional Care should give an opportunity to offer support and enhanced 
access to treatments known to impact on drug deaths, to this vulnerable group.  
Fifty of the 70 deaths which occurred within 6 months of release, were known to 
be long term dependent users yet only 34 were offered access to Transitional 
Care.  This may reflect the organisation of the Transitional Care services, 
including their inclusion and exclusion criteria.  In some establishments there 
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Case study  
A 30-year-old male who died on the day of liberation from prison.  Post 
mortem states he died of heroin intoxication.  He had a history of moderate 
mental health problems dating back some 10 years – diagnosed as suffering 
from depression and anxiety which had been treated by his GP with 
antidepressants.  He was also known to be opiate dependent having been an 
IV user for three years.  The prison mental health team had assessed him 
regarding suicide risk and organised a GP appointment on his liberation day 
but he failed to attend.  He was socially isolated, having lost contact with his 
family and was homeless, having given up his tenancy on entering prison in 
July 2003.  He was liberated to a friend’s home, claiming to be drug free.  He 
was found dead in the bathroom having injected heroin. 
were clearly practical barriers to access – with one having no access to 
Transitional Care at all, one accepting only self-referrals (of which none of the 
DRD group availed themselves) and one having waiting lists.  Some of the 70 
may have received interim liberation or may have been released from court, in 
which circumstances they would not be in a position to be offered or to accept 
Transitional Care.  There are varying degrees of success from establishment to 
establishment, regarding conversion of the offer to an accepted intervention.  
Some prisons converted 100% of offers while in others as little as one in three 
accepted the offer.  Improving identification of this group, increasing the number 
offered such support and increasing the numbers accepting the offer gives 
potential for impacting on drug-related deaths after release from prison. 
 
Conclusions 
 
This chapter highlights the fact that the majority of those dying of drug-related 
causes in Scotland in 2003 were known to at least one service with some known 
to many.  They were mainly accessing generic service providers and the services 
they accessed tended to reflect local service distribution.  In all areas this contact 
was mainly with their General Practitioner or Primary Care team.  Other generic 
services were regularly accessed in emergency situations including Accident & 
Emergency and Acute Psychiatry services.  Repeated contacts were common but 
there was little evidence of a coordinated response or follow up.  There are clearly 
opportunities to intervene in this group which have not been fully exploited – 
including education of generic services and improved coordination of response to 
those repeatedly presenting to services.  This work should involve Psychiatry and 
Accident & Emergency services. 
 
Those in contact with specialist services were mainly accessing medical treatment 
(such as methadone replacement prescribing) or Social Work interventions.  Only 
17% of those known to services were in receipt of replacement prescribing 
services at the time of death.  Most methadone prescribing was through General 
Practice.  Records of assessment and decisions regarding prescription alteration – 
dose increase or reduction; dispensing arrangements etc. - are poor.  Most were 
prescribed low doses of methadone and few also received supportive counselling.  
There is a need to improve the demonstrable quality of prescribing treatments 
and to improve access to supportive counselling interventions which may impact 
on risk for this group. 
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Key Points 
 
 
• There is a need to improve the quality of note keeping, in both community-
based services and those within the Scottish Prison Service, to allow closer 
scrutiny of the care received. 
 
• Most people suffering drug-related deaths were known to services and many 
were accessing more than one. 
 
• These services are often generic (i.e. not specialists in the field of substance 
misuse) and were often accessed in an ad hoc, chaotic manner.  Most were 
discharged with inadequate follow up in place or failed to attend any such 
follow up appointments resulting in discharge and no further action. 
 
• There is a need to increase awareness of this problem and to deliver training 
and improved coordination for those generic staff most likely to come into 
contact with this group – General Practitioners, Psychiatric services, Accident 
& Emergency and Social Work. 
 
• Specific medical interventions for drug misuse were only accessed by a 
minority of these people.  When accessed they were often prescribed 
methadone. 
 
• Methadone replacement prescribing should be delivered alongside supportive 
psychosocial interventions, including counselling – which was only accessed by 
a small minority of the prescribed group. 
 
• Methadone should be prescribed in line with the current evidence base – 
following a full assessment of drug problems and dependency; in adequate 
doses to meet need; dispensed safely and effectively under supervision until 
the person is demonstrably stable. 
 
• Many had been in prison in the last 6 months.  Ten died within 3 days of 
release of which 6 were released on a Friday.  There is a need to ensure that 
effective communication takes place to ensure imprisonment does not 
interrupt treatment (if being accessed before incarceration) or that it gives an 
opportunity to increase access to treatment if not already in contact with 
services.  DAATS should review the care pathways across the 
community/prison interface and ensure adequate accessibility to services for 
all newly released prisoners. 
 
• Transitional Care is not being made available to all who require it.  Prisons 
show varying success regarding take-up rates. 
 
• There is a need to ensure all opportunities are taken to intervene when drug 
misusers are in prison.  Prisons should look proactively at how they engage 
with prisoners at the start of their treatment cycle. 
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What is in this chapter?  This section of the report describes the findings 
from extended interviews with a sample of overdose survivors. 
Where did the information come from?  Injectors were interviewed as 
part of an ongoing study of IDUs’ risk behaviours.  Those who had survived 
an overdose in the six months prior to interview were invited to take part in 
an extended interview of structured open-ended questions to obtain relevant 
information surrounding their experiences that may inform prevention 
strategies. 
Chapter 6:  Experiences of overdose survivors  
 
Sample characteristics 
Of the 595 living injectors recruited into the ongoing study evaluating the change 
in the Lord Advocate’s guidelines on the supply of needle and syringes to injecting 
drug users, ninety-seven (16.3%) had overdosed at least once in the previous 6 
months and, of these, 40 (41.2%) completed an extended interview. 
At least one attempt was made to contact most overdose survivors.  However, 
some IDUs had either changed their address and contact details in between the 
first and follow-up interviews, were not available when interviewers called at their 
address or had changed their minds about being interviewed. 
Table 6.1 shows the characteristics of the 40 IDUs who were followed up.  The 
majority (32, 80%) were male, mean age was 33.5 years and mean length of 
injecting was 11.8 years.  Respondents had experienced a mean of 1.6 overdoses 
in the previous six months and five (13%) survivors had overdosed intentionally 
at their last overdose. 
 
Table 6.1: Characteristics of 40 overdose survivors who completed an 
extended interview 
 
Mean age (years) 33.5 
Males (n) 32 
Mean time since onset of injection 
(years) 
11.8 
Ever been in treatment (n) 34 
In treatment at last overdose (n) 14 
Last overdose intentional (n) 5 
Mean number of overdoses in last 
six months 
1.6 
 
 
Knowledge of risk factors/overdose prevention 
 
Several factors were mentioned as overdose risks by IDUs.  “Mixing drugs”, 
particularly heroin and benzodiazepines was the most frequently cited (n=18).  
Alcohol in conjunction with either or both heroin and benzodiazepines was also 
mentioned by 6 IDUs. 
 
After mixing drugs, loss of tolerance was the next most recognised risk, cited by 
17 respondents.  In a few cases (n=8) this factor was mentioned in association 
with release from prison. 
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On the same theme as tolerance, 11 IDUs mentioned that “having too much 
heroin” was risky and five blamed the purity of heroin for overdoses. 
 
Other risks identified included being on one’s own when injecting (n=7), “greed” 
(n=3) and “chasing”/wanting to experience an overdose” (n=2). 
 
Risk taking behaviour 
 
All respondents were asked about the drugs they had taken on the day of their 
last overdose.  Number of drugs taken ranged from one to four.  One drug had 
been involved in 6 cases, two drugs in 14 overdoses, three drugs in 6 cases and 
four drugs were reported in 3 overdoses.  Eleven overdoses had involved alcohol; 
on five occasions this had been taken in conjunction with two drugs, on three 
occasions with three drugs and another three overdoses had involved alcohol and 
one drug (table 6.2). 
 
Table 6.2: Number of drugs taken at last overdose 
 
Number of drugs taken Number of respondents 
1 6 
2 14 
3 6 
4 3 
1 + alcohol 3 
2 + alcohol 5 
3+ alcohol 3 
 
 
Heroin had been taken in all but one of the reported overdoses.  In all 31 
overdoses involving two or more substances, heroin and diazepam were involved 
together in 21 cases.  In the 14 overdoses involving two drugs, the most common 
combination was heroin and diazepam (n=9).  In all 39 overdoses involving 
heroin, it was administered intravenously.  Diazepam had been taken in 22 
overdoses, in all but one of these episodes it was taken orally and on one 
occasion it was injected.  In the only overdose in which heroin was not consumed 
the cocktail of drugs included methadone, cocaine, benzodiazepine (type of 
benzodiazepine was not stated by respondent) and alcohol. 
 
Methadone was implicated in 7 overdoses, always in combination with other 
substances.  Cocaine was involved in 9 overdoses, in combination with other 
substances, and injected on all occasions. 
 
Dosages ranged widely. Four overdose survivors claimed to have overdosed on 
one £10.00 bag of heroin.  At the other end of the spectrum, one respondent 
reported drinking two bottles of vodka, half a bottle of bourbon, swallowing 
100mg of diazepam and injecting £20.00 of heroin in the course of one day.  
Another reported consuming 300mg of diazepam, £20.00 of cocaine, £20.00 of 
heroin (the latter two injected) and one bottle of whisky. 
 
Seven of the forty IDUs reported that they had recently (within the previous two 
weeks) been released from prison.  Amounts of substances consumed on the day 
of overdose amongst this group tended to be lower compared with other 
respondents.  Two of those recently released had each overdosed on one £10.00 
bag of heroin; another had overdosed on £10.00 of heroin and 50mg of diazepam 
and one had overdosed on one quarter of a £10.00 bag of heroin and 170mg of 
diazepam.  Reported substance consumption of the remaining three who were 
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recently liberated was 80mgs of diazepam, one bottle of fortified wine and an 
unspecified amount of other alcohol; one £10.00 bag of heroin, 10mg of 
diazepam and four cans of super lager; a half gram of cocaine and one £20.00 
bag of heroin, respectively. 
 
Reasons for surviving overdose 
 
When asked why they thought they had survived their most recent overdose, by 
far the most common response (n=25) was that someone else had been present 
at the time.  A further four IDUs had had someone present when they overdosed 
but ascribed their survival to “luck”.  Nine respondents had been on their own and 
attributed their survival to “luck”, “God” or having been found in time.  Amongst 
the five who had overdosed intentionally, four had been on their own and, of 
these, three had been found by someone. 
 
Why treatment did not help prevent overdose 
 
Fourteen overdose survivors had been in treatment at the time of their last 
overdose.  All but one was receiving prescribed methadone.  Respondents were 
asked why they thought treatment had not prevented them from overdosing.  
Four could not give a reason; five IDUs attributed their overdose to topping up on 
other substances whilst prescribed methadone; two of these claimed that their 
methadone was “not enough”; a further two respondents believed it to be due to 
the purity of heroin they had taken (although these two IDUs were also receiving 
methadone). One respondent said that it was “a bad mood” which led to the 
overdose and another IDU claimed that treatment staff “ did not give enough 
time to talk”.  Two of the 14 in treatment had overdosed intentionally. 
 
Why not in treatment 
 
The 26 IDUs who had not been in treatment at the time of overdose gave a wide 
variety of reasons for this.  These included “just out of prison” (n=6) or out of 
rehabilitation (n=1), not wanting methadone (described by one IDU as “the 
devil”) because of severe withdrawal effects (n=3); laziness or apathy, “just 
couldn’t be bothered”, “hadn’t got round to it” (n=3); not being able to access 
treatment (n=3); wanting to control/cut down consumption by themselves (n=2), 
not wanting to stop drug use (n=2), treatment being a waste of time (n=1); to 
get access to children (n=1); not needing treatment (n=1); not encouraged by 
anyone to seek treatment (n=1). Two respondents gave no response to this 
question. 
 
Overdose Prevention 
 
The most frequently quoted prevention strategy was to inject when someone else 
was present (n=13) (table 6.3).  Nine IDUs suggested that safe injecting facilities 
would help prevent overdoses.  Respondents also suggested ways in which 
awareness of overdose could be raised among IDUs.  These included the provision 
of videos (n=8) or leaflets (n=7), although two respondents pointed out that 
leaflets were not suitable for IDUs with reading difficulties.  It was also suggested 
that life-saving or resuscitation methods should be taught to IDUs (n=3).  Four 
respondents thought that heroin should be legalised and two suggested that there 
should be a facility to test the purity of heroin. 
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Table 6.3: Overdose prevention strategies most frequently suggested by 
40 overdose survivors who completed an extended interview 
 
Strategy Number of respondents* 
Inject with someone present 13 
Safe injecting facilities 9 
Information videos 8 
Information leaflets 7 
Legalise heroin 4 
Resuscitation or life-saving classes 3 
Facilities to test purity of heroin 2 
*Respondents could give more than one answer 
 
Overdose Interventions 
 
When asked what should be done when someone has overdosed, half (n=20) of 
the sample mentioned the recovery position.  Nine referred to giving the “kiss of 
life” and four to giving CPR. Calling an ambulance was cited by nine respondents. 
 
Inflicting physical pain, however, was the most commonly reported intervention 
method.  Twenty-eight respondents stated that slapping or punching was the way 
to bring someone out of an overdose.  Some serious physical assaults were 
reported, including one respondent who showed the interviewers two burn marks 
that had been inflicted on him by a friend on one overdose occasion.  Twenty-one 
IDUs mentioned water as a revival mechanism.  This ranged from applying a 
damp cloth to the person’s face to throwing a bucket of water over them or 
putting ice down the person’s back.  Other revival methods included walking the 
victim around (mentioned by 17 IDUs) or talking to the victim (n=9). The most 
frequently mentioned interventions are set out in Table 6.4 below. 
 
Table 6.4: Overdose interventions most frequently mentioned among 40 
overdose survivors who completed an extended interview 
 
Intervention Number of respondents* 
Slapping/punching 28 
Applying water 21 
Put in recovery position 20 
Walk victim around 17 
Talk to victim 9 
Give “kiss of life” 9 
Call an ambulance 9 
CPR 4 
*Respondents could give more than one answer 
 
 
Nineteen IDUs had received training in resuscitation techniques, mainly in prison 
or treatment agencies.  Yet, despite their training, even some of these 
respondents reported inflicting pain. One respondent explained why: 
 
“In the jail I have been taught……[that] all that walking about and 
slapping, putting water on is doing the wrong thing. Put them in the 
recovery position, phone an ambulance. But it is hard to [do this] 
when one of your own is lying there going pure blue…..and even if I 
know the right thing to do is to put them in the recovery position, and 
I’ve done it a few times in jails but that is all dummies and there is no 
panic, but see at the real thing you panic, you don’t know what to 
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do….. All you can think of is, if you go away and leave him and then 
come back and he is dead, my family would never forgive me”. 
 
Respondents also spoke of barriers to intervening in an overdose situation.  Fear 
of the police, particularly fear that they would be arrested and blamed if the 
victim died, was the greatest barrier.  This concern often resulted in IDUs either 
not reporting the overdose or not staying to help the overdose victim.  One hostel 
dweller claimed “a lot of people die because others don’t want to go downstairs 
[in the hostel] and say “he’s overdosed””. 
 
Personal perceptions of overdose risk 
 
Thirteen IDUs thought that they would not have another overdose.  This belief 
was mainly based on the changes they had made following their last overdose.  
Respondents reported that they had either cut down or stopped consumption of 
all or some drugs.  Nine IDUs thought that they would have another overdose; 
one respondent replied that overdose “goes with the territory”.  Six respondents 
believed that they probably would overdose and the remaining sample did not 
know if another overdose was likely. 
 
Half of the sample (n=20) reported that they were worried about having another 
overdose and 17 IDUs stated that they did not worry about this.  However, when 
probed a bit further, some of the 17 explained that they were not worried 
because they did not care if they lived or died.  “Yes and no [I’m worried] 
because I don’t want to die but at the same time I don’t see much point in living 
at times”. 
 
Overdose myths 
 
In the course of the interviews it became apparent that some IDUs held 
erroneous beliefs about overdose.  Five IDUs believed that smoking heroin would 
not lead to overdose; one respondent claimed that overdose would not occur if 
heroin was injected by itself and not in combination with other substances; one 
thought that it was not possible to overdose on methadone; another stated that, 
in a drug cocktail of heroin and diazepam, if the diazepam was consumed first 
there would be a danger of overdose, if heroin was taken first there would be no 
danger of overdose. 
 
Other myths surrounded appropriate overdose interventions.  One IDU stated 
that “you won’t overdose if somebody is with you, if they are slapping you”.  On 
the same theme, another respondent claimed that “If you keep saying their name 
and you really care about that person, then they’ll come round”. 
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Key points 
 
 
• Injecting drug users are aware, to some extent, of the overdose risks, 
although this knowledge is not extensive. Less than half mentioned loss of 
tolerance as a factor and less than half considered that a mixture of drugs 
could be risky. 
 
• The majority of overdoses occurred amongst those who had taken more than 
one substance on the day of overdose. 
 
• Heroin had been taken in all but one overdose.  Heroin and diazepam taken 
together or on the same day was the most common combination, taken in 22 
cases.  In fifteen overdoses heroin and diazepam were the only drugs 
consumed; in the remaining five episodes they were taken in combination 
with one or two other substances and/or alcohol. 
 
• Injecting with someone else present was the most frequently cited prevention 
strategy. 
 
• Inflicting physical pain was the most common intervention used by injecting 
drug users.  Although putting the overdose victim into the recovery position 
was cited by half the sample, the infliction of pain was still regarded as the 
most effective strategy. 
 
• There were some misconceptions about overdose risk factors.  Some injecting 
drug users believed that overdose would not occur if heroin was smoked or if 
it was injected by itself. 
 
• Half of the sample was worried about having another overdose.  Among those 
who were not worried, some claimed not to care whether they lived or died. 
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What is in this chapter?  This chapter reviews the findings from individual 
chapters and draws together a final set of conclusions along with associated 
implications for service commissioners and providers. 
 
Where did the information come from?  The information has been drawn 
from the “key points” sections from each chapter in the body of the report. 
 
Chapter 7:  Conclusions and Implications 
 
Introduction 
 
This investigation has comprehensively examined the circumstances of death, 
social circumstances and service contacts of those dying of drug-related causes in 
Scotland in 2003.  It has also considered long-term trends in drug-related deaths 
in Scotland and has compared the circumstances of the 2003 Scottish deaths with 
data from a concurrent study into drug-related deaths in London for the same 
year.  Finally the investigation has explored the opinions, beliefs and knowledge 
of living injectors regarding overdose risk. 
 
The developing evidence-base implies that many drug-related deaths may be 
preventable and this investigation aimed to identify areas which, if effectively 
addressed would impact on the rate of drug-related deaths in Scotland. 
 
Each chapter of the report has therefore identified “Key Points” based on the data 
collected. These are summarised below and have been used to generate 
implications for service commissioners and providers arising from the findings of 
this investigation. 
 
Describing the study population and trends over time 
 
Most Scottish drug related deaths in 2003 were male, and in their early 30s 
(mean age of 32.7 years).  Most were considered to have been accidental drug 
overdoses (based on ICD-10 criteria for drug related deaths), although a sizeable 
13% were classified as suicides.  These characteristics are consistent with 
previous published studies into drug related deaths. 
Trends in drug-related deaths in Scotland from 1996 to 2003 were complex and 
showed a great deal of heterogeneity over time in relation to geographical 
distribution and the involvement of heroin/morphine or methadone.  Drug-related 
deaths involving heroin/morphine had increased at a significantly higher rate than 
those involving methadone in Scotland during 1996-2003 (13.8% vs –0.4% per 
year, respectively).  In Glasgow, however, deaths involving methadone increased 
at a higher rate (average 9.7% per year) than deaths involving heroin (which 
increased at an average 6.5% per year). 
Drug-related deaths involving heroin/morphine had increased at a significantly 
higher rate out-with the main urban centres of Glasgow and Lothian during 1996-
2003, and likely relates to the growth of drug use in these areas.  Overall, there 
were twice as many deaths involving heroin/morphine as methadone.  However, 
the ratio of heroin/morphine : methadone overdose deaths varied considerably 
between geographical areas – for example, from 117 : 26 in Lanarkshire to 21 : 
70 in Tayside and 59 : 175 in Lothian. 
A higher proportion of methadone compared to heroin/morphine–related deaths 
in Scotland occurred at the weekend (defined as Friday to Sunday). Drug-related 
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deaths increased at a significantly higher rate among those aged 35-54 compared 
to 15-24 years during 1996-2003. 
 
Implications 
 
The study and analysis showed important differences in drug-related deaths over 
time and geographically.  However other studies will be required to test potential 
explanations and hypotheses for these differences.  One key question is to what 
extent do the differences follow, and are due to, the underlying trends and 
pattern in drug use in Scotland?  Or are there differences in the availability and 
delivery of treatment, and investigation of drug-related deaths, that may have a 
bearing on the mortality statistics and mortality rate within Scotland. 
  
Toxicological findings and circumstances of death 
 
1. There were missed opportunities to intervene and save the lives of many of the 
people who died.  Less than half had tried CPR and most cases had died by the 
time the ambulance arrived. 
 
Implications 
 
There is a need to develop and deliver training and education for drug users and 
their families to increase awareness of the risks of overdose, how to avoid it, how 
to identify it and how to respond effectively. 
 
2i). Benzodiazepines were the most common drugs detected in drug-related 
deaths.  Few cases were positive for psychostimulants, in particular cocaine.  The 
predominant drugs found at the time of death continue to be heroin/morphine, 
benzodiazepines and alcohol in Scotland. 
 
2ii). Nearly half of methadone related deaths, and two-thirds of diazepam and 
dihydrocodeine positive deaths involving illicitly obtained medications. 
 
Implications 
 
The widespread ingestion of benzodiazepines in particular diazepam among drug 
users (as indicated by the toxicology data for the current sample of deaths, and 
by the data on trends in drug-using characteristics of cases of drug related death 
during 1996-2003 in Scotland) is a matter of major concern regardless of whether 
these drugs were implicated in the cause of these deaths.  Benzodiazepines are 
potential drugs of dependence with risks of both acute and chronic adverse 
psychological, physical and social sequelae for misusers.  More research is needed 
into the prevention and management of benzodiazepine abuse. 
  
The findings also suggest that illicit manufacture and/or diversion of prescribed 
drugs is a substantial source of drugs for users, and remains a significant issue 
for health service providers and others in the field.  Where diversion of prescribed 
drugs e.g. dihydrocodeine or methadone and/or benzodiazepines, may be 
occurring, there is a need to address prescribing practices in relation to these 
drugs.  However any further analysis of illicit sources of medications would have 
involved collection of data on the illicit manufacture of prescription medications, 
which did not form part of this investigation. 
 
3. A relatively high proportion of cases did not inject any drugs prior to overdose 
and death.  A high proportion was also positive on toxicological analysis for only 
orally consumed drugs.  Drug users who do not inject heroin (or other drugs) are 
also at risk of fatal drug overdose. 
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Implications 
 
The findings reported here suggest that overdose prevention initiatives should 
continue to reinforce the message that most fatal drug ‘overdoses’ are polydrug 
deaths and alert drug users that for a substantial number of cases, ‘lethal’ drugs 
are not necessarily injected drugs. 
Services must be aware of the risks of non-injecting, in particular oral drug use, 
and must continue to warn drug users and the broader community of the dangers 
of combinations of drug use including alcohol.  Drug treatment services may also 
need to be aware that non-injecting dependent drug (in particular licit drug) and 
alcohol users, may not be attracted into seeking help because they may not 
identify with these agencies’ illicit drug using and/or injecting clientele. 
 
4. Analysis of cause of death information showed that the same drug-related 
cause of death may be recorded on the death certificate by forensic authorities in 
various ways.  It also found that while ‘opiate intoxication’ was the most 
frequently recorded cause of death for drug related deaths in Scotland, being 
recorded for 131 (44%) cases, in only 12 (9%) cases was toxicology positive only 
for opiates.  In the vast majority of opiate intoxication cases, toxicology identified 
other drugs in addition to opiates, most frequently benzodiazepines and alcohol. 
 
Implications 
 
That post-mortem toxicological results are not always reflected in the certified 
cause of death could suggest either under-reporting on the death certificate of 
other drugs detected or more likely that other drugs detected were not 
considered to be implicated in the cause of death. 
 
The task of attributing cause of death to one or more of a number of drugs 
detected at post-mortem is a complex and inherently fraught one in the case of 
many drug-related deaths.  However, under current cause of death nomenclature, 
the prevalence of polydrug use, and in particular the widespread involvement of 
‘licit’ orally consumed drugs in cases of drug related death, may be 
underestimated. 
The systematic collation and availability of forensic toxicological data would assist 
the surveillance and/or analysis of trends in drug-related fatalities.  Developing a 
more standardised, uniform nomenclature for recording drug-related deaths on 
medical certificates would also improve the monitoring and researching of drug-
related deaths. 
  
5. There were a higher number of deaths positive for dihydrocodeine and 
benzodiazepines in Scotland, and a higher number of deaths positive for cocaine 
in London. There were a higher number of cases in receipt of dihydrocodeine 
prescriptions in Scotland, and lower average blood concentrations of methadone 
and morphine in Scotland. 
 
Implications 
 
These key differences, which might reflect differences in the pattern of drug use 
and treatment provision between Scotland and London, could be explored further. 
 
6. In Scotland, a higher proportion of deaths (17% vs. 10%) were associated 
with recent prison release (i.e. within three months of release) compared with 
London. 
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Implications 
 
Part of the difference may possibly be explained by differences in services 
provision between the two sites.  The larger proportion of deaths with a recent 
prison history in Scotland, which is a recognised risk factor for drug related 
mortality, is worthy of further investigation. 
 
Social circumstances prior to death 
 
1. Information, as it is currently collected across Scotland is sparse, inconsistent 
and difficult to cross-reference. 
 
Implications 
 
Use of a standardised, well-validated method of collecting agreed data on all drug 
deaths would substantially facilitate the identification of relevant social risk 
factors. 
  
2. The lack of up to date relevant information in many of the casefiles, which 
would be required to organise an integrated care plan is a concern.  The 
availability of rich, up to date information would allow identification and 
prioritisation of potential risk factors in this vulnerable population which could 
reduce future morbidity and mortality and must form part of good practice in the 
management of drug misusers. 
 
Implications 
 
Staff in all settings should be trained to comprehensively and holistically assess 
drug misusers and to ensure that regular updates of essential information (e.g. 
regarding childcare responsibilities, life events etc.) are recorded.  Nationally, 
standards could be set within the DAT Corporate Action Plan requiring recording 
of adequate information.  Locally, DATs and their health and Local Authority 
partners could ensure that services are commissioned with clear quality standards 
and monitoring procedures in place. 
 
Contact with services 
 
1. Most people who died of drug-related causes were known to services and many 
were accessing more than one.  These services were often generic (i.e. not 
specialists in the field of substance misuse) and were often accessed in an ad hoc, 
chaotic manner.  Following this contact, most were discharged with inadequate 
follow up in place or failed to attend any such follow up appointments resulting in 
discharge and no further action. 
 
Implications 
 
There is a need to increase awareness of this problem and to deliver training and 
improved coordination of activity for those generic staff most likely to come into 
contact with this group – General Practitioners, Psychiatric services, Accident & 
Emergency and Social Work. 
 
2. Medical interventions were only accessed by a minority.  When accessed, the 
intervention was often prescribed methadone.  Quality of methadone prescribing 
was often outside that contained in national practice guidelines. Few of those 
prescribed methadone were in receipt of any counselling. 
 
 65
Implications 
 
Methadone replacement should be prescribed only in line with the current 
evidence base – following a full assessment of drug problems and dependency; in 
adequate doses to meet need; dispensed safely and effectively under supervision 
until the person is demonstrably stable. Methadone replacement prescribing 
should be delivered alongside supportive counselling. 
 
3. Many had been in prison in the last 6 months.  Ten died within 3 days of 
release of which 6 were released on a Friday.  Transitional Care is not being made 
available to all who require it.  Prisons show varying success regarding take-up 
rates. 
 
Implications 
 
There is a need to ensure all opportunities are taken to intervene when drug 
misusers are in prison. In particular, there is a need to ensure that effective 
communication takes place to ensure imprisonment does not interrupt treatment 
(if in treatment before incarceration) or that it gives an opportunity to increase 
access to treatment if not already in contact with services. DAATS should review 
the care pathways across the community/prison interface and ensure adequate 
accessibility to services for all newly released prisoners. Prisons should look 
proactively at how they engage with prisoners at the start of their treatment 
cycle. 
 
Experiences of overdose survivors 
 
The majority of overdoses occurred amongst those who had taken more than one 
substance on the day of overdose.  Heroin had been taken in all but one 
overdose.  Heroin and diazepam taken together or on the same day was the most 
common combination, taken in 22 cases.  In fifteen overdoses heroin and 
diazepam were the only drugs consumed; in the remaining five episodes they 
were taken in combination with one or two other substances and/or alcohol. 
 
Injecting drug users are aware, to some extent, of the overdose risks, although 
this knowledge is not extensive.  Less than half mentioned tolerance as a factor 
and less than half considered that a mixture of drugs could be risky.  There were 
some misconceptions about overdose risk factors.  Some injecting drug users 
believed that overdose would not occur if heroin was smoked or if it was injected 
by itself.  Injecting with someone else present was the most frequently cited 
prevention strategy. 
 
Inflicting physical pain was the most common intervention used by injecting drug 
users.  Although putting the overdose victim into the recovery position was cited 
by half the sample, the infliction of pain was still regarded as the most effective 
strategy.  Half of the sample was worried about having another overdose.  Among 
those who were not worried, some claimed not to care whether they lived or died. 
 
Implications 
 
There is a need to develop and deliver training and education for drug users and 
their families to increase awareness of the risks of overdose, how to avoid it, how 
to identify it and how to respond. 
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Conclusion 
 
This investigation has identified a number of implications for services in the 
prevention of future drug-related deaths in Scotland.  It has highlighted some 
limitations of fiscal and national registry office data on drug-related mortality and 
has raised aspects of drug-related deaths requiring further research. 
 
Finally, the report provides some baseline indicators by which the potential 
effectiveness of interventions to prevent or reduce drug related deaths in future 
might be measured.  Some of these outcome measures might include improved 
after care from prison, improved delivery of methadone treatment, and increased 
engagement of drug users with services especially drug treatment services. 
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Appendix 1 
 
Notes on the definition of 'drug-related' deaths 
 
1. The definition of a 'drug-related death' is not straightforward.  A useful 
discussion on the definitional problems may be found in an article in the Office for 
National Statistics publication Population Trends.  More recently, a report by the 
Advisory Council on the Misuse of Drugs (ACMD) considered current systems used 
in the United Kingdom to collect and analyse data on drug related deaths.  In its 
report, the ACMD recommended that 'a short life technical working group should 
be brought together to reach agreement on a consistent coding framework to be 
used in future across England, Wales, Scotland and Northern Ireland'.  GROS was 
represented on this group and this paper presents information on drug-related 
deaths using the approach agreed. 
2. The baseline covers the following cause of death categories (the relevant codes 
from the International Classification of Diseases, Tenth Revision (ICD10), are 
given in brackets): 
a. deaths where the underlying cause of death has been coded to the 
following sub-categories of 'mental and behavioural disorders due to 
psychoactive substance use':  
i. opioids (F11);  
ii. cannabinoids (F12);  
iii. sedatives or hypnotics (F13);  
iv. cocaine (F14);  
v. other stimulants, including caffeine (F15);  
vi. hallucinogens (F16); and  
vii. multiple drug use and use of other psychoactive substances (F19).  
b. deaths coded to the following categories and where a drug listed under the 
Misuse of Drugs Act (1971) was known to be present in the body at the 
time of death:  
i. accidental poisoning (X40 - X44);  
ii. intentional self-poisoning by drugs, medicaments and biological 
substances (X60 - X64);  
iii. assault by drugs, medicaments and biological substances (X85); 
and  
iv. event of undetermined intent, poisoning (Y10 - Y14).  
3. Categories of death excluded: 
a. deaths coded to mental and behavioural disorders due to the use of 
alcohol (F10), tobacco (F17) and volatile substances (F18);  
b. deaths coded to drug abuse which were caused by secondary infections 
and related complications (for example the 20 or so deaths in 2000 caused 
by clostridium novyi infection);  
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c. deaths from AIDS where the risk factor was believed to be the sharing of 
needles;  
d. deaths from road traffic and other accidents which occurred under the 
influence of drugs; and  
e. deaths where a drug listed under the Misuse of Drugs Act was present 
because it was part of a compound analgesic or cold remedy: specific 
examples are:  
Co-proxamol: paracetamol, dextropropoxyphene 
Co-dydramol: paracetamol, dihydrocodeine 
Co-codamol: paracetamol, codeine sulphate 
f. All three of these compound analgesics, but particularly co-proxamol, are 
commonly used in suicidal overdoses. 
g. Note: As it is believed that dextropropoxyphene is rarely if ever available 
other than as a constituent of a paracetamol compound, it has been 
ignored on all occasions (even if there is no mention of a compound 
analgesic or paracetamol).  However, deaths involving codeine or 
dihydrocodeine without mention of paracetamol have been included in the 
baseline as these drugs are routinely available on their own and known to 
be abused in this form. 
 
Source: General Register Office for Scotland (2004) Drug related deaths in 
Scotland in 2003. 
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Appendix 3 
 
 Figure A3.1: Distribution of blood morphine concentrations (n=176) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.2: Distribution of blood methadone concentrations (n=80) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A3.3: Distribution of blood alcohol concentrations (n=153) 
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Table A3.4: Comparison of drug related deaths in Scotland and 
London 
 
Characteristic Scotland London 
Test of 
Difference 
Total 273 148  
Sex           
% (n) male 81.7% (223) 81.1% (120) NS* 
Age      
Mean (median) age 31.8 (31) 35.7 (34) p < 0.001^ 
Toxicology           
Heroin/morphine 65.6% (179) 66.9% (99) NS* 
Methadone 30.4% (83) 31.8% (47) NS* 
Cocaine 9.9% (27) 41.9% (62) p < 0.001* 
MDMA/Amphetamines 9.5% (26) 12.2% (18) NS* 
Alcohol 54.9% (150) 56.1% (83) NS* 
Benzodiazepines 69.2% (189) 40.5% (60) p < 0.001* 
Dihydrocodeine 18.7% (51) 10.8% (16) p = 0.03* 
Mean (median) heroin toxicology 
(mg/L) 
0.27 (0.2) 0.36 (0.26) p = 0.045^ 
Mean (median) methadone 
toxicology (mg/L) 
0.52 (0.309) 0.87 (0.54) p < 0.01^ 
Mean (median) alcohol toxicology 
(ml/100ml) 119.6 104 87.1 59 
p = 0.01^ 
Substitute treatment      
yes 25.6% 70 27.7% 41 NS* 
methadone  17.9% 49 25.0% 37 NS* 
DHD 8.4% 23 2.7% 4 p=0.03* 
Deaths with positive methadone 
toxicology and evidence of 
methadone prescription  
51.8% 43 55.3% 26 NS* 
Deaths with positive DHD toxicology 
and evidence of DHD prescription  
35.3% 18 12.5% 2 NS* 
Prison history      
yes 47.6% 130 40.5% 60 NS* 
released < 3 months 17.2% 47 10.1% 15 p=0.05 
Witness present      
yes 48.4% (132) 60.8% (90) p < 0.01* 
Ambulance called           
yes 81.7% (223) 90.5% (134) p < 0.05* 
If ambulance called, dead on 
arrival 
     
yes 85.2% (190) 85.1% (114) NS* 
Known IDU           
yes 53.8% (147) 60.8% (90) NS* 
Route of fatal dose      
Inject 54.6% (149) 64.9% (96) p < 0.05* 
Non-inject 43.6% (119) 26.4% (39)  
Not able to be determined 11.7% (32) 10.8% (16)  
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Table A3.4: Comparison of drug related deaths in Scotland and 
London (Continued) 
 
Characteristic Scotland London 
Test of 
Difference 
Usual type of accommodation           
house/flat 81.3% (222) 67.6% (100) p < 0.01* 
hotel/motel 2.9% (8) 2.7% (4)  
hostel resident 7.3% (20) 7.4% (11)  
street homeless 1.8% (5) 5.4% (8)  
caravan/camper/car 0.7% (2) 2.0% (3)  
roofless/sofa surfer 4.0% (11) 6.8% (10)  
other 0.0%  4.1% (6)  
unknown 1.8% (5) 4.1% (6)   
Place of death      
own home 47.6% (130) 43.9% (65) NS* 
home of family/friend 27.1% (74) 20.3% (30)  
hotel/motel/hostel 8.8% (24) 11.5% (17)  
public space 3.7% (10) 7.4% (11)  
hospital 8.8% (24) 11.5% (17)  
other 3.7% (10) 4.7% (7)  
unknown 0.4% (1) 0.7% (1)  
Time of death          
Rapid/instant 9.2% (25) 6.8% (10) p < 0.01* 
Within the hour 15.4% (42) 6.1% (9)  
Several hours 44.7% (122) 27.7% (41)  
12 hours or more 2.9% (8) 3.4% (5)  
A number of days 0.7% (2) 3.4% (5)  
Not able to be determined 27.1% (74) 52.7% (78)   
      
Note: ^ T-test, * Chi2       
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Appendix 4 
Table A4.1: List of potential interventions offered to cases of drug-
related death in the 6 months prior to death (n=237) 
 
A. SOCIAL B. MEDICAL 
  
1. Food distribution 20. Medical consultation 
2. Clothes washing 21. Other medical care 
3. Clothing distribution 22. General hospitalisation 
4. Shower/hygiene 23. Nursing care 
5. Help finding accommodation 24. General emergency 
6. Night shelter 25. General prevention and health 
promotion 
7. Accommodation  
8. Emergency social accommodation D. MENTAL HEALTH 
9. Social reintegration, help finding 
work 
 
10. Legal/administrative advice or 
aid 
60. Emergency psychiatric care 
11. Financial assistance 61. Outpatient psychiatric 
consultation 
12. Travel expenses 62. On-site delivery of 
psychotropic treatment 
13. Prison work 63. Individual psychotherapy 
14. Prison Transitional Care/Community 64. Psychiatric hospitalisation 
 65. Family therapy 
C. CARE STRATEGY 66. Group therapy 
 67. Psychological consultation 
80. Somewhere to sit 68. Occupational therapy 
81. A place to talk 69. Discussion groups 
82. Low threshold/drop in  
83. Case management E. SUBSTANCE ABUSE 
84. To speak to Mr/Mrs X  
85. Information and orientation 40. Substance misuse assessment 
86. Support and training for carers 41. Substitution programme 
87. Holistic care 42. Detoxification (short term 
reduction) 
88. Street outreach work 43. On-site needle/syringe exchange 
89. Care at client’s home 44. Outreach needle/syringe 
exchange 
90. Day care 45. Counselling 
91. Advocacy 46.  Drug Treatment & Testing 
Order 
 47.  Put on Waiting list 
 48. Motivational enhancement 
Interventions highlighted in bold text are those which were recorded as 
having been offered to individuals. 
 80
Table A4.2: Prescribing details of cases in methadone treatment at time of 
death (n=40) 
 
Case ID Dose at 
death (mg) 
Duration of last 
dose (weeks) 
Previous dose 
(mg) 
Duration of 
methadone treatment 
(months) 
134 - - - - 
246 4 3 6 7 
152 10 5 days 12 5 
8 16 6 15 N/K*** 
202 20 3 13  7 
175 30 1 day 10 16 
136 30 - nr 82 
144 30 - 35 88 
32 30 7 days 50 30 
259 35 24 40 N/K 
216 40 10 days 30 2 
169 45 - nr N/K 
174 45 9 35 5 
271 45 15 35 37 
287 45 - nr N/K 
187 45 10 days 40 5 
190 50 - 30 N/K 
198 50 4 40 6 days 
73 50 3 days Nr 3 days 
132 50 12 40 N/K 
282 50 20 55 N/K 
252 50 4 40 5 
262 50 21 45 6 
232 50 7 days 40 19 
 50 14 40 18 
 60 8 55 10 
234 60 8 days 50 73 
 65 2 58 84 
166 65 4 60 5 
76 70 2 Nr <1 
54 80 -* Nr** N/K 
204 80 - 70 2 
206 80 16 70 17 
220 80 2 days Nr 2 days 
118 80 - Nr N/K 
24 90 32 80 5 
61 90 5 Nr 1 
256 90 4 110 5 
7 95 52 100 40 
108 100 52 Nr 12 
    *-=no information 
  **nr=no dose change recorded in notes 
***N/K=not known
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